OFAB Aesthetics Wholesale - Full Audit v2 (Niche-Aware, B2B Medical-Supply Variant)

Site: ofab.ie (canonical, in-progress) | ofabaestheticswholesale.ie (current live, 301 source)

Date: 2026-05-08

Prepared for: Friday call with Harvinder Bhogal + James (9 May 2026, 12:00 Madrid)

Author: Online Optimisers (Donal)

Audit type: Full audit v2, eight-phase, B2B medical-supply variant per sops/seo/ecom-audit-template.md

Scope: Tech SEO + on-page + E-E-A-T + backlinks + CRO + AI ranking probe + regulatory landmines + weaponisable assets

---

Phase 0 - Brief and Context

OFAB Aesthetics Wholesale is a trade-only B2B supplier of professional aesthetic injectables, devices, and consumables to Irish-registered clinics, doctors, nurse prescribers, and certified practitioners. The business positions itself as Ireland's only same-day Dublin trade supplier. The two-domain situation is a deliberate consolidation: ofabaestheticswholesale.ie is the current live store; ofab.ie is the new short brand domain Donal recommended; a 301 chain is planned but not necessarily live at the time of this audit. Harvinder Bhogal is the SEO-aware founder; James is the cashflow-cautious co-owner. Forty-plus recent Google reviews dated Jan-Feb 2026 confirm the business is actively trading.

The market is Ireland-first, with optional UK and EU spillover. Buyers are clinics, not consumers. The product mix is dominated by HA dermal fillers (Profhilo, Revolax, Teosyal, Teofil, Lumifil, Aessoa, Regenovue), skin boosters and bio-stimulators (Sunekos, Jalupro, Plenhyage XL, Nucleofill, Plinest, Ejal40), fat dissolvers (Aqualyx by Marllor BioMedica, Lemon Bottle, Skinny Bottle, Lipo Lab, Kairax), polynucleotides (Nucleofill, Plenhyage XL, Plinest), exosomes (Exoblanc, ILLUMA), microneedling, mesotherapy cocktails (Vitaran, Citrus Bottle), skin peels, hair fillers, and consumables (cannulas, needles, sharps containers).

Three Harvinder-validated head competitors are johnbannonpharma.ie, rosevel.ie, and healthxchange.ie. Audit-surfaced competitors include filler-boutique.com (same-day Dublin dispatch, deep brand catalogue overlap, surfaced as the most direct undisclosed threat), dermadirect.ie, cityaesthetics.ie, bodyscent.ie, and aestheticsource.com. UK distributors competing for IE attention include Wigmore Medical, Church Pharmacy Aesthetics, Med-fx, and Hamilton Fraser Cosmetic.

Five validated keywords from Harvinder are: skin boosters, aesthetics suppliers, aesthetics wholesale, fat dissolvers, dermal fillers. The audit treats these as the head-term backbone and expands into 50-plus long-tail variants, brand-name modifiers, and Irish-city qualifiers.

---

Phase 1 - Tech SEO Snapshot

Verdict on technical floor: WordPress plus WooCommerce plus Yoast plus a healthy robots.txt and a Yoast sitemap is a competent technical floor. It is also a default floor; nothing here is differentiated. The audit cannot confirm Core Web Vitals, schema completeness, mobile usability, or indexation count without GSC and live Lighthouse access. These three live checks become Day 1 retainer tasks rather than blockers to closing.

1A - The In-Progress 301 Migration QA

This is the single most important technical workstream of the next 30 days, and OO wants to own it. Migrations are won or lost on six specific gates, every one of which is non-negotiable.

Gate 1: Canonical lock and 301 chain. Every URL on ofabaestheticswholesale.ie must 301-redirect to its exact-equivalent slug on ofab.ie. The redirect must be a single hop (not chained), preserve query strings where appropriate, and apply at the server level (not via meta refresh or JavaScript).

Gate 2: GSC property migration. Both domain properties must exist in Google Search Console. The Change of Address tool must be used after the 301s are confirmed live. Sitemap on the old property is left submitted until the new one fully indexes. Inspection sample of the top 50 URLs by impressions must show the redirect crawl.

Gate 3: Internal-link rewrite. Every internal link in the WordPress database that points at ofabaestheticswholesale.ie must be updated to ofab.ie. This is a Better Search Replace job (or equivalent), run on wp_posts, wp_postmeta, wp_options, and any custom tables. Skipping this leaves the site relying on 301s for internal navigation, which loses crawl budget and dilutes equity.

Gate 4: Anchor-text refresh on referring sites. Backlinks pointing at ofabaestheticswholesale.ie should be cleaned where possible. Reach out to high-value referrers (brand-stockist pages, directory listings) to update anchor and target. Where outreach is impractical, the 301 carries the equity, but direct refresh is preferred.

Gate 5: Schema and Open Graph refresh. Organization schema, sameAs links (Instagram, LinkedIn, Google Business Profile), Open Graph URLs, Twitter cards, and structured data references all need to swap from the long domain to the short. Yoast handles most of this once the canonical site URL is changed in WordPress general settings, but verify after the swap.

Gate 6: Email, social, GMB, and brand-stockist directory updates. Every external-facing reference - GMB listing, Instagram bio, LinkedIn company page, brand-side stockist pages, supplier directories like Safety in Beauty Ireland - must be checked and updated. Email signatures, invoices, packing-slip URLs, and any printed material need a parallel update path.

Migration QA package, free, as the wedge: OO offers to own all six gates as a no-charge sprint within the first 30 days of the retainer (or as a one-off if no retainer signs). Botched migrations lose 30 to 60 percent of organic equity for 6 to 12 months; a clean migration loses zero. This is the single highest-leverage technical task on the table.

1B - Outstanding Tech Items After Migration

After the 301 stabilises (week 4), the next wave of technical workstreams is:

• Schema rollout: Product schema with full Offer fields (price, priceCurrency, availability, GTIN, brand, manufacturer, MPN), Organization schema with sameAs, LocalBusiness schema for the Coolock address, FAQPage schema on every category and brand hub, BreadcrumbList everywhere
• Core Web Vitals fix pass: image WebP conversion, lazy-loading audit, render-blocking script audit, font-loading audit
• Mobile UX audit: tap-target sizing, viewport rendering, mobile-specific CTA placements
• Internal-link cleanup: orphan-page audit (any product not linked from at least one category), category-to-pillar-content linking once pillars exist, brand-page interlinking
• WooCommerce performance: object-cache layer (Redis or W3 Total Cache), CDN routing for media (Bunny.net or Cloudflare), database optimisation
• HTTP/2 push, preload key fonts, eliminate render-blocking on the homepage hero

1C - Gaps Around B2B-Specific Tech

Most B2C ecom audits stop at Core Web Vitals and schema. B2B aesthetic supply has additional layers:

• Practitioner-only gating implementation. Today the catalogue is open. Best practice for trade-only sites (Healthxchange, Wigmore Medical, Med-fx) is a soft-gate or hard-gate: visitors register, upload practitioner verification (IMC/NMBI registration number, qualification cert, clinic insurance), and only then see prices. This is both a CRO lever and a regulatory protection (see Phase 7).
• Trade-only price hiding. Even before full gating, prices should be hidden from logged-out users on prescription-adjacent products. WooCommerce + B2BKing handles this natively.
• MOQ display logic. Some products carry minimum order quantities or volume-tier pricing. The product page schema and on-page UX should display this clearly.
• Trade-account VAT logic. Irish VAT-registered buyers must be able to enter VAT numbers and see correct tax calculations. UK and EU buyers (post-Brexit) need correct treatment too.
• Bulk order flow. Quote-request and bulk-purchase order flows are typical B2B tooling not present on consumer-style WooCommerce stores.

---

Phase 2 - On-Page Assessment

2A - Homepage

H1 is "Ireland's Leading Aesthetics Wholesaler" - keyword-aligned, single H1 confirmed.

H2 ladder includes "Built for Professionals", "Why Clinics and Practitioners Choose OFAB", "What We Supply", and "Trusted by Clinics and Practitioners". This is a competent B2B framing.

Word count is approximately 2,500 to 3,000 words, which is heavy for a homepage and good for ranking head terms. The homepage is doing more work than most pages on the site.

Title tag is "Home - OFAB Aesthetics Wholesale" which is weak. It should be "Aesthetic Wholesale Ireland | OFAB | Same-Day Dublin Dispatch" or similar - keyword-led with a unique selling proposition. This is a 5-minute fix.

Meta description was not directly inspected. Flag for QA. The pattern for the new template is two sentences, primary keyword in the first, USP in the second, soft CTA at the end (max 155 characters).

2B - Category and Shop Pages

Approximately 50-plus products are visible on shop landing. Product descriptions on category listings are minimal: names plus thumbnails plus price. There is no introductory category copy, no FAQ, no comparison guidance, no clinical-protocol context. Category pages typically need 300 to 500 words of intro copy on a B2B medical-supply site to rank for category-level head terms ("dermal fillers Ireland", "skin boosters Ireland"). Today they look templated and thin.

2C - Product Detail Pages (PDPs)

Without crawling every PDP, the pattern visible from sample inspection is templated WooCommerce: product title, price, short description, add to cart, long description (often 100 to 300 words), reviews block. This is below the bar for B2B medical supply, where competitors like Wigmore Medical and Church Pharmacy carry 1,200 to 2,000-word PDPs covering indication, mechanism of action, ingredient list, manufacturer credentials, regulatory status (CE mark, HPRA-listed where relevant), clinical-protocol guidance, complication management, storage, and batch traceability.

Recommendation: rebuild the PDP template with a structured block system - Indication / Mechanism / Ingredients / Manufacturer credentials / Regulatory status / Suggested protocol / Storage and shelf-life / Pairs well with / FAQs. Each block populated by a custom field set, so PDPs scale at the rate of cataloguing, not at the rate of long-form copy.

2D - Brand Pages

Brand-page architecture is present (one page per stocked brand). Likely template-driven. The opportunity is "buy [brand] Ireland" long-tail dominance: Profhilo Ireland, Sunekos Ireland, Lemon Bottle Ireland, Aqualyx Ireland, Plenhyage XL Ireland, Revolax Ireland, Nucleofill Ireland, Teosyal Ireland, Jalupro Ireland, Vitaran Ireland. Twelve brand pages, each with 800 to 1,500 words covering manufacturer credentials, indication, comparable alternatives in the catalogue, Irish-clinic protocol notes, and a clear "official Ireland stockist" claim. This is among the highest-ROI on-page workstreams in the 90-day plan.

2E - Blog Content

Zero. The blog is empty. This is the largest on-page gap on the site. The 5-cluster, 59-page hub-and-spoke plan in blog-plan/topical-cluster-strategy.md addresses this in full.

2F - Trust Hub Pages

The site lacks a coherent trust hub. Specifically missing:

• Founder bio with credentials (Harvinder's ecom background, James's role, year established, why aesthetics)
• Year established and trading history
• Professional body affiliations or aesthetics industry memberships
• Named clinic case studies (40-plus reviews exist but are not linked to clinic names with consent)
• Certification page (sharps disposal, batch traceability, cold-chain handling for biologic products)
• Regulatory page (CE mark explanations, HPRA references, ASAI 7th compliance posture)
• Press mentions or industry features (none currently)
• "Why us" page with concrete differentiators (today the homepage carries this load, alone)

A simple six-page trust hub - About / Founder / Compliance / Case Studies / Press / Why OFAB - would close the perception gap with Healthxchange in 30 days.

2G - Internal Linking

Standard WooCommerce taxonomy linking only: products to categories, categories to brands, brands to products. No editorial cross-linking from blog into product pages because there is no blog. Once pillars exist, the spoke-to-money-page link distribution must be designed deliberately rather than left to default WooCommerce behaviour.

2H - Title and Meta Pattern

Recommended pattern for the rebuild:

• Homepage: Aesthetic Wholesale Ireland | OFAB | Same-Day Dublin Dispatch
• Category: [Category] Ireland | Trade Wholesale | OFAB Aesthetics
• Brand: [Brand] Ireland | Official Trade Supplier | OFAB
• Product: [Product Name] | [Brand] | OFAB Aesthetic Wholesale Ireland
• Pillar: [Question or topic in plain English] | OFAB Practitioner Guide
• Spoke: [Specific topic or comparison] | OFAB Aesthetic Wholesale

Title tags carry the primary keyword first, brand last. Meta descriptions describe the page's unique value plus a soft CTA in 150 characters.

---

Phase 3 - E-E-A-T Audit (B2B Medical-Supply Lens)

E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness) is the single biggest gap on the site. For a B2B medical-supply business, this is not a soft signal: it is the buyer's primary risk filter. Clinics buying injectables are placing patient safety, professional indemnity, and HPRA compliance on the line every time they choose a supplier. Suppliers without visible E-E-A-T markers lose to suppliers with them, regardless of price.

3A - Experience Signals

3B - Expertise Signals

3C - Authoritativeness Signals

3D - Trustworthiness Signals

3E - The E-E-A-T Stack to Build

A six-page trust hub closes most of the gap:

• About OFAB (history, founders, year established, mission)
• Founder Story - Harvinder Bhogal + James (visible names + credentials)
• Compliance and Regulatory Posture (CE marks, HPRA-adjacency, ASAI 7th statement, batch traceability, cold-chain)
• Clinic Case Studies (3 to 5 named, consented Irish clinics with usage stories)
• Press and Industry Mentions (whatever is real now, plus growing list as PR ramps)
• Why OFAB (the differentiator panel: same-day Dublin, MOQ flexibility, founder-accessibility, integrated tooling)

Plus author pages (one per blog contributor) with credentials and sameAs links. Plus a clinical-reviewer page. Plus a privacy and T&Cs rewrite for trade context.

3F - The Founder-Bio Specific Gap

Harvinder is publicly visible (LinkedIn, YouTube channel @chartingbtc, ecom-dev background, Ireland-to-Madrid relocation). James is publicly less visible. Both are absent from the OFAB website. This is the single most surprising omission for a B2B medical-supply business: clinics buying from OFAB have no idea who runs OFAB. A founder page with photos, credentials, and 600 to 800 words of context costs a day to produce and immediately shifts the site from "anonymous wholesaler" to "founder-led trade supplier", which is the same delta Healthxchange leans on with its 25-year heritage story.

---

Phase 4 - Backlink Position

4A - Baseline (Indicative, Pending Live API Pull)

This audit did not run Ahrefs, SEMrush, Moz, or DataForSEO backlink data. Schedule a live pull within Day 1 of any retainer.

Indicative signals from manual search results:

• Domain age: not confirmed but Instagram presence suggests 2 to 3 years active
• Brand mentions found: Instagram (@ofabaestheticswholesale), the second domain ofabaestheticswholesale.ie (self-referential), no major industry-press mentions surfaced
• Press mentions: zero surfaced in basic search
• Likely current Domain Rating: low, estimate 5 to 15
• Likely referring domains: under 50
• Anchor distribution: not measured

4B - The Backlink Strategy Stack

Five pillars of backlink acquisition for the next 90 days:

Pillar 1 - Aesthetic-industry directories. Safety in Beauty Ireland, Aestheticsource (UK directory listing IE suppliers), Aesthetic Journal IE, Beautyguild, IAPN (Irish Association of Plastic and Cosmetic Nurses) supplier-list page if eligible. Expected 5 to 8 links in 30 days.

Pillar 2 - Brand-side stockist pages. Every brand stocked has a "where to buy" or "find a stockist" page on the manufacturer's site. Profhilo via IBSA, Sunekos via Professional Derma, Plenhyage XL via Mastelli, Aqualyx via Marllor BioMedica, Lemon Bottle, Revolax via Across, Teosyal via Teoxane, Nucleofill, Ejal40 via Regenyal Laboratories, Jalupro, Vitaran. Outreach to each manufacturer for an "official Irish stockist" listing. Expected 6 to 10 links in 60 days.

Pillar 3 - Irish business directories. GoldenPages, Yelp IE, Local.ie, Hotfrog, Cylex, BIA. These are easy, low-quality but volume-cumulative. Expected 8 to 12 links in 30 days.

Pillar 4 - Industry press. Irish Tatler, RSVP, Image.ie, Aesthetics Journal IE, Cosmetic News UK, Beautyworld News, Aesthetic Practitioner. Pitch ghost-written articles by Harvinder on topics like "How the Irish aesthetic supply chain has changed in 2026" or "What Irish clinic owners need to know about the new ASAI 7th edition rules". Expected 2 to 4 links in 90 days.

Pillar 5 - Tier-2 PR and partnerships. Aesthetic-clinic-owner podcast appearances, IAPN webinar sponsorship, IMCAS-IE event partnership, CCR Aesthetics trade show sponsorship at minimum-tier. Expected 2 to 4 links in 120 days.

4C - The Anti-Pattern to Avoid

Do not run a generic guest-post backlink campaign on cheap aesthetic-blog-network sites. The IE aesthetic regulatory frame (ASAI 7th, IMC, HPRA) means that low-quality content with off-brand efficacy claims could expose Harvinder to enforcement risk. Backlinks must come from credible aesthetic-industry, Irish-business, or trade-press sources, not from generic SEO-network sites.

---

Phase 5 - CRO and Conversion Path Audit

5A - The Practitioner-Only Gate

Today the catalogue is fully open. Anyone can browse, see prices, and reach checkout. Best-practice trade-only sites (Healthxchange, Wigmore Medical, Med-fx) gate the catalogue: visitors must register, upload verification, and only then see prices and add to cart.

Argument for soft-gate (recommended): Visitors see categories, brand pages, and product imagery and descriptions, but prices are hidden. To see prices and add to cart, they register. Verification (IMC/NMBI number, qualification cert) is a follow-up step that unlocks volume tiers and trade pricing. Registration takes 30 seconds; verification takes 24 to 48 hours.

Argument for hard-gate (alternative): Nothing is visible without registration. This is the Healthxchange pattern. Higher friction, higher trust signal, lower SEO surface area.

Recommendation: Soft-gate. Preserves SEO surface area (category and brand pages remain indexable), provides a clear trade-only signal without losing organic traffic, and creates a registered-clinic count that becomes a brand brag stat ("trusted by 250-plus Irish clinics").

Implementation: B2BKing or Wholesale Suite WooCommerce plugin handles role-based price hiding, registration gating, and trade-tier pricing natively.

5B - Registration Flow

Today's flow is unclear. Recommended flow:

Step 1 - Brief form (name, email, clinic name, role, IMC/NMBI/IAPN/MGPS membership type)

Step 2 - Auto-create account, send verification email

Step 3 - Email link triggers a verification-document upload (registration cert, insurance cert)

Step 4 - 24 to 48 hour manual review by Harvinder or James

Step 5 - Approval triggers welcome email plus first-order discount voucher and trade-tier pricing visibility

This converts a passive catalogue browser into a verified, named, contactable lead with regulatory-compliance documentation on file.

5C - Cart and Checkout

Stripe Connect or Stripe + Klarna for trade are recommended. Specific items to audit:

• Cart page: cross-sell logic (recommend complementary products like cannulas with fillers)
• Shipping methods: Dublin same-day, IE next-day, UK next-day, EU 3 to 5 days
• VAT logic: Irish VAT inclusive for IE buyers, VAT-exempt for VAT-registered EU buyers, UK B2B VAT logic post-Brexit
• Bulk-order quote-request flow for high-volume clinics
• Repeat-order convenience: saved carts, one-click reorder

5D - GMB and Local Pack

The Coolock address and 40-plus recent reviews are strong signals. Audit items:

• GMB listing optimisation: business category accuracy, Q&A management, post cadence, photo upload cadence
• Review-response policy: every review replied to within 48 hours
• Citation consistency: NAP (Name, Address, Phone) identical across all 30-plus directories
• Local pack ranking for "aesthetic wholesaler Dublin" and "aesthetic supplier near me" (Dublin-area searches)

5E - Lead Magnet and Email Capture

Today there is likely a generic newsletter signup. Recommended replacements:

• "The Irish Clinic Owner's Compliance Checklist" (PDF download, lead magnet) - captures email plus clinic name plus role
• "Profhilo vs Sunekos vs Plenhyage: a clinic protocol decision tree" (gated content) - mid-funnel
• "Free 60-day trial price-list access" (registration prompt for new clinics)

Each magnet builds a segmented email list (new clinic / established clinic / multi-site) for tier-relevant follow-ups.

5F - On-Site Trust Conversion Triggers

• Live chat (or chatbot) with practitioner-aware logic (the demo asset for Friday)
• "Speak to your account manager" CTA with named contact and direct dial
• "Same-day Dublin dispatch" countdown widget on PDPs ("Order in next 2h 14m for same-day dispatch")
• Stock-level transparency ("12 in stock - replenishment Tuesday")
• Recently-ordered ticker ("A clinic in Cork ordered 6 vials of Profhilo 30 minutes ago") - opt-in only

---

Phase 6 - AI Ranking Probe (Stub)

Full 200-cell matrix in ai-audit-deep-v1.md. Summary stub here.

Twelve buying-intent queries probed mentally against ChatGPT, Perplexity, Claude (web), and Google AI Overviews. Indicative findings (organic SERP signal, not live AI run):

• For "aesthetics wholesale supplier Ireland dermal fillers": top organic ranks Rosevel, Derma Direct, international suppliers. OFAB does not appear top 10.
• For "skin boosters wholesale Ireland B2B": Rosevel, Filler Boutique, Bodyscent, Skinboosters.ie, Bioresus dominate. OFAB does not appear top 10.
• For "aesthetics suppliers Ireland directory professional": OFAB appears (split between domains), alongside Rosevel, Healthxchange, City Aesthetics, AestheticSource, Safety in Beauty.
• For "where to buy dermal fillers Ireland clinic supplier": dominated by Irish CLINICS not suppliers.

Likely AI behaviour: for supplier-intent queries, AI engines most likely cite Rosevel, Healthxchange, and Filler Boutique because of content depth and ref-domain count. OFAB is likely invisible in AI answers today on the 5 validated keywords. This is the OO sales hook.

The migration to ofab.ie, in progress, is the moment to lock canonical signals onto the new domain rather than fragmenting AI memory across both. Failure to QA the migration risks a 6 to 12-month invisibility hangover even from current low base.

Per Rule 05: framing is "increased likelihood of citation", not "ranked number 1 in AI". The 90-day target is to be cited in at least 1 of the 5 validated keyword AI answers (today: 0).

---

Phase 7 - Regulatory Landmines (Ireland-Specific)

This is the section most B2C audit skills miss. For a B2B aesthetic supplier in Ireland, regulatory exposure is the single biggest commercial risk vector after cashflow.

7A - ASAI 7th Edition (Advertising Standards Authority for Ireland)

The ASAI 7th edition Code (effective 2024) introduced significant restrictions on advertising prescription medicines and aesthetic procedures in Ireland. Key obligations for OFAB:

• Marketing of prescription-only medicines (POMs) directly to consumers is restricted. Botox, dermal fillers in some categories, and prescription-only injectables fall under POM regulations.
• Trade-only marketing to qualified practitioners is permissible but must be clearly gated.
• Claims about efficacy must be substantiated and cannot be misleading.
• Before-and-after imagery is restricted in consumer-facing marketing.
• Influencer marketing of POMs is heavily restricted.

OFAB-specific obligations:

• Marketing copy on the public-facing site must avoid making efficacy claims about prescription-only injectables for consumers.
• The trade-only positioning is a partial protection but the practitioner-only gate must be visible and enforceable.
• Blog content must be carefully written to inform practitioners (B2B audience) rather than to sell to consumers.
• Email marketing must be segmented and respect ASAI 7th rules per audience.

ASAI compliance posture should be a visible page on the site, drafted with regulatory specificity, demonstrating that OFAB understands and respects the rules. This is a trust signal as much as a compliance shield.

7B - HPRA (Health Products Regulatory Authority)

HPRA is the Irish regulatory authority for medicines and medical devices.

• Most dermal fillers and biostimulators are classified as medical devices (CE-marked) rather than medicines.
• Some products (Botox, certain prescription-only fillers) are POMs and require prescriber-only supply chains.
• HPRA registration of clinics handling POMs is a clinic-side obligation, not OFAB's, but OFAB must verify practitioners' eligibility before supplying POMs.
• Adverse-event reporting obligations: OFAB as a distributor of CE-marked devices has a duty to facilitate adverse-event reporting upstream to manufacturers and to HPRA where required.
• Batch traceability is non-negotiable.

Compliance content to publish on site:

• A Regulatory Status page explaining CE-marking, POM classifications, and HPRA-adjacent obligations
• A Batch Traceability page describing how OFAB handles batch records and supports clinic-side traceability
• An Adverse Event Reporting page with clear instructions for clinics

7C - IMC (Irish Medical Council) and NMBI (Nursing and Midwifery Board of Ireland)

These are the registration bodies for prescribers in Ireland. OFAB's practitioner-verification process should map to these:

• IMC-registered doctors can prescribe POMs.
• NMBI-registered nurse prescribers can prescribe POMs within their scope.
• Non-prescribers (aestheticians, beauty therapists) can administer some non-POM products under prescriber oversight in certain models.
• The registration verification step should request and validate IMC/NMBI numbers and surface the prescriber's authorised scope.

7D - GDPR and Practitioner Data

Practitioner verification documents (registration certs, qualification certs, insurance certs, ID) are sensitive personal data under GDPR. OFAB must:

• Obtain explicit consent for collection and storage
• Articulate retention periods
• Provide a clear right-to-erasure pathway
• Use a GDPR-compliant document storage system (not just an email inbox)

A privacy policy rewrite specifically for trade-only data flows is needed.

7E - Cross-Border Trade and Brexit Implications

• Sales to UK clinics: post-Brexit, UK is a third country. VAT, customs declarations, MHRA implications all apply.
• Sales to EU clinics: VIES VAT validation for VAT-registered buyers, OSS reporting for B2C edge cases.
• Importing from non-EU manufacturers (Korean fat dissolvers, some Korean fillers): customs and CE-mark validation.

7F - The Compliance Toolkit as a Competitive Asset

Most competitors do not openly publish their compliance posture. A visible, well-written compliance section turns regulatory diligence into a marketing asset and an E-E-A-T signal. The recommended bundle:

• Public Compliance and Regulatory Posture page
• Public ASAI 7th Compliance Statement
• Public Batch Traceability and Cold-Chain page
• Public Adverse Event Reporting guidance
• Internal SOPs for practitioner verification, audit trails, and HPRA correspondence (not public, but referenced on the public page)
• Quarterly compliance review by external regulatory consultant (1 to 2 days per quarter, EUR 1,500 to 3,000 annual cost)

This is among the highest-trust-leverage actions OFAB can take, and Healthxchange does not currently lead with it.

---

Phase 8 - Weaponisable Assets (What OFAB Already Has That Most Competitors Lack)

8A - 40-Plus Recent Google Reviews

Reviews are the single most underutilised asset OFAB has. Currently they live on GMB. Recommended weaponisation:

• Embed review widget on homepage and every category page
• Pull 5-star reviews into named clinic case studies (with consent)
• Use review-pull-quotes in product PDPs, email marketing, and PR materials
• Create a "What Irish clinics say" hub page with full review feed
• Schema markup: AggregateRating on Organization schema, Review schema on case studies

8B - Same-Day Dublin Dispatch

This is a genuine differentiator vs Healthxchange (UK warehouse), Rosevel (likely IE warehouse but pace not stated), and Filler Boutique (claims same-day Dublin too, so this is a parity point not a solo edge). Same-day Dublin is competitive, not unique. The OFAB twist is to surface it more aggressively on the homepage hero, in metas, and in PDP buttons ("Order in next 2h 14m for same-day Dublin dispatch").

8C - Brand Catalogue Breadth

The brand list (Profhilo, Sunekos, Plenhyage XL, Aqualyx, Lemon Bottle, Revolax, Teosyal, Nucleofill, Ejal40, Jalupro, Vitaran, plus Aessoa, Regenovue, Lumifil, Citrus Bottle, Skinny Bottle, Kairax, Exoblanc, ILLUMA, Plinest, Lipo Lab, Teofil) is genuinely broad. This is a 20-plus-brand catalogue, which beats most IE single-manufacturer distributors. The weaponisation is a Brand Comparison Hub: a single page that lists every brand stocked, with quick-jump anchor links to brand pages, plus head-to-head comparison spokes (Profhilo vs Sunekos vs Plenhyage; Aqualyx vs Lemon Bottle; Revolax vs Teosyal).

8D - Coolock Dublin Address and Irish Phone Number

Authentic Irish supply chain. Use in every metadata field, every footer, every contact card. Pin in GMB, surface in PR.

8E - VAT Invoice on Every Order

This is a B2B credibility signal that B2C sites do not match. Prominent on the homepage trust-bar, prominent in checkout, prominent in email confirmations.

8F - Free Delivery Over EUR 299

Standard B2B incentive. Use in cart-abandonment emails, in PDP urgency messaging, and in volume-tier marketing.

8G - Order-Now-Pay-Later (Klarna-Style for Trade)

Mentioned on the site, not heavily surfaced. For cashflow-sensitive new clinics, BNPL trade financing is a closing tool. Make it a persistent banner during checkout for new accounts.

8H - Founder Accessibility (Latent Asset)

Harvinder is the founder, public on LinkedIn and YouTube, ecom-experienced. Most B2B aesthetic suppliers hide their founders. A "talk to the founder" button on the contact page (Calendly-routed for screening) is a unique trust signal that no incumbent currently offers.

8I - Trade-Tier Pricing Logic (To Build)

Not currently surfaced. Once built (B2BKing plugin), the volume-tier pricing visible to verified accounts becomes a switching cost that reinforces retention. Tier 1 (small clinic, 0 to 5k EUR/quarter) standard pricing; Tier 2 (5k to 20k) 5 percent discount; Tier 3 (20k+) 10 percent plus dedicated account manager.

8J - Owned Email List (To Build)

If 250 clinics register via the trade gate over 12 months, that is an owned list with deep behavioural data (what categories they browse, what they order, what they re-order). This is more valuable than any single SEO ranking and is the compounding asset of the next 24 months.

---

Final Summary - Top 7 Fixes Ordered by Impact

---

Flagged for Manual Verification Before Proposal

• Core Web Vitals via Lighthouse on homepage, top 3 categories, top 5 PDPs
• Schema validation via schema.org validator on homepage and 1 PDP
• Backlink data live pull (Ahrefs, SEMrush, or DataForSEO)
• GSC indexation count vs sitemap count (request access during onboarding)
• Live AI probes on the 12 anchor queries
• Domain split status: confirm whether 301 chain is currently live or pending
• johnbannonpharma.ie strengths (WebFetch returned 403 in v1; manual review pending)
• T&Cs, privacy policy, and returns policy current state
• B2BKing or Wholesale Suite or B2B For WooCommerce plugin selection
• Stripe vs Stripe + Klarna for trade configuration

---

Sales Framing Notes (Private)

• Lead with Migration QA as the wedge. Free, immediate, and protects everything downstream.
• Use Harvinder's own 5 validated keywords verbatim.
• Of three named competitors: Healthxchange = premium incumbent, Rosevel = direct head-to-head, johnbannonpharma = pharma adjacency. Sell against Rosevel hardest.
• Hidden competitor to flag: filler-boutique.com (same-day Dublin, same brand catalogue overlap). The "we did our homework" moment.
• Pricing: EUR 3-5k/m anchor, freebies-not-discount approach.
• James-flips risk: payment-clear trigger only, no verbal commitments.

---

End of Ofab full audit v2.

OFAB Competitor Mega-Table v2 - IE + UK Aesthetic Supplier Landscape

Version: 2.0 Date: 2026-05-08 Owner: Online Optimisers

For: Friday 9 May 2026 call with Harvinder Bhogal + James

Scope: 12 direct B2B aesthetic-supplier competitors across IE and UK, doctor-level analysis. Per Rule 09, only real B2B trade-supplier competitors are listed; consumer clinics, directories, and aggregators excluded.

---

Executive Summary

Twelve competitors mapped across three concentric rings:

• Ring 1 - Direct IE B2B trade suppliers (5): rosevel.ie, johnbannonpharma.ie, healthxchange.ie, filler-boutique.com, dermadirect.ie
• Ring 2 - IE-adjacent and dual-territory (3): cityaesthetics.ie, bodyscent.ie, aestheticsource.com
• Ring 3 - UK distributors competing for IE attention (4): Wigmore Medical, Church Pharmacy Aesthetics, Med-fx, Hamilton Fraser Cosmetic / FUSION GT

Three findings stand out:

• Filler Boutique is the most direct undisclosed threat. Same-day Dublin dispatch, deep brand catalogue overlap with OFAB, very similar value proposition, and Harvinder did not name them on his competitor list. This is the doctor-level finding.
• Healthxchange's moat is structural not catalogue. The catalogue can be matched. Healthxchange Academy (training + content + practitioner community) is the lever, and Cluster 5 of OFAB's content plan is the counter.
• The UK 4 (Wigmore, Church, Med-fx, Hamilton Fraser) compete primarily for IE clinics that haven't yet found an IE supplier. Geo-locking IE-specific buying-intent SERPs is the easiest defence. Same-day Dublin closes the deal once SERP visibility is won.

---

The 17-Column Mega-Table

(Doctor-level analysis follows for each competitor below.)

---

Doctor-Level Analysis Per Competitor

Ring 1 - Direct IE B2B Trade Suppliers

1. Rosevel (rosevel.ie)

Why it's threatening: Same head terms, same IE B2B audience, similar mid-tier price point. Loyalty programme and "tree planted per order" is a soft emotional hook OFAB does not yet match. Rosevel was Harvinder's own brand before the shares dispute, so the team knows the playbook.

Where it's beatable: Founder accessibility - Rosevel's founder narrative is muted. Same-day Dublin - Rosevel is IE next-day, OFAB is same-day Dublin, and the Dublin clinic concentration matters. Pillar content - Rosevel's blog is brand-led basic, the 5-cluster plan exceeds it within 90 days.

Doctor's note: The shares dispute (per chat context) means Harvinder cannot reference any prior Rosevel work, and treating Rosevel purely as competitor is the correct posture. Sell hardest against Rosevel.

2. John Bannon Pharma (johnbannonpharma.ie)

Why it's threatening: Pharmacy heritage and regulatory ceiling. Prescriber-only clinics buying POMs go to a pharmacy first.

Where it's beatable: Slow, narrow on aesthetics specifically, no aesthetics-content depth, no community, no training, no chatbot. Pharmacy is a wide remit; aesthetics-specialist beats it on speed and breadth-within-niche.

Doctor's note: Don't try to outrank for "Botox supplier Ireland" against a regulated pharmacy - that's an unwinnable fight on regulatory ground. Win on non-POM injectables (HA fillers, skin boosters, fat dissolvers, polynucleotides) where OFAB's product breadth and speed win.

3. Healthxchange (healthxchange.ie / .com)

Why it's threatening: Premium incumbent with 25-year heritage, Healthxchange Academy training moat, gated practitioner-only login (correct B2B posture), curated premium brand list (Obagi, Medik8, Jan Marini, Heliocare alongside injectables), multiple sister platforms (Clever Clinic for clinic-tech, Clever Beauty for retail, Healthxchange Devices for capital equipment), affiliated marketing channels and events.

Where it's beatable: UK-flavoured. Healthxchange Academy content does not address Irish regulatory specifics (HPRA, IMC, ASAI 7th edition). OFAB's Cluster 1 (Becoming an Aesthetic Clinic in Ireland) is uncontested ground. Healthxchange's brand-agnostic content avoids head-to-head brand comparisons because it sells competing brands; OFAB can be opinionated. Healthxchange's premium ceiling makes price-conscious solo clinics walk to OFAB or Filler Boutique. Same-day Dublin beats UK fulfilment + IE next-day.

Doctor's note: Don't compete on heritage - that's a 25-year fight OFAB cannot win. Compete on Irish-specificity, founder accessibility, brand-opinionated content, price floor, and same-day Dublin.

4. Filler Boutique (filler-boutique.com)

Why it's the most threatening competitor (and Harvinder did not name them): Same-day Dublin dispatch is parity, not OFAB advantage. Brand catalogue (Profhilo, Nucleofill, Seventy Hyal, Ejal40, Plenhyage, Dermaheal) overlaps with OFAB's. Anonymous brand identity is a weakness not a strength but they nonetheless compete head-to-head on the exact lanes OFAB targets.

Where it's beatable: No public founder. No published compliance posture. No clinic case studies. Generic trust signals (CE badges only). No training or community. No integrated stack. The catalogue and speed are matched; everything else is OFAB's wedge.

Doctor's note: This is the Friday-call "we did our homework" moment. Showing the SERP grid where Filler Boutique appears for queries OFAB doesn't reframes OFAB's invisibility from "you have weak SEO" to "you have a real and named competitor moving on your ground". Harvinder will respect the surfacing. The next 90 days are about closing parity (catalogue + speed) and pulling ahead on E-E-A-T and integrated tooling.

5. Derma Direct (dermadirect.ie / .com)

Why it's threatening: Pricing-led commodity competitor. "Integral partner" positioning sounds B2B but the content and trust signals are thin.

Where it's beatable: Brand depth, content depth, founder visibility, clinical reviewer signals. Derma Direct competes on price floor only - the soft-gate plus trust hub plus content depth pulls verified-clinic accounts away from price-only buyers into relationship-driven buyers.

Doctor's note: Treat as the lower tail of the IE direct competitor set. Don't engineer the offer around them; engineer around Rosevel and Filler Boutique, and Derma Direct loses by absorption.

Ring 2 - IE-Adjacent and Dual-Territory

6. City Aesthetics (cityaesthetics.ie)

Why it's threatening: Premium central-Dublin physical address (14 Dame Street, Dublin 2) gives them walk-in trade plus delivery. Premium positioning targets the Dublin 2 / Dublin 4 high-end clinic segment.

Where it's beatable: Geographic - they own central Dublin walk-in, OFAB owns same-day-to-all-of-Ireland. Volume - they're a niche premium player, OFAB's broader catalogue scales beyond central-Dublin niche.

Doctor's note: Co-existence is fine. Don't engineer to displace City Aesthetics; engineer to own non-Dublin-2 IE clinic supply.

7. Bodyscent (bodyscent.ie)

Why it's threatening: Adjacent rather than direct. Bodyscent is a beauty wholesaler with thin injectables. They overlap on consumables and skincare, not on dermal fillers and skin boosters.

Where it's beatable: Stay focused on injectables-led aesthetic supply. Let Bodyscent own skincare wholesale.

Doctor's note: Don't engineer the OFAB offer to compete on skincare; that's a different niche with different buyers.

8. Aesthetic Source (aestheticsource.com)

Why it's threatening: Training-first positioning. New-grad practitioners (a growing IE segment) buy from training-led suppliers because the supplier helps them get certified to inject what they're buying.

Where it's beatable: OFAB's OOB Idea catalogue includes a Practitioner Training Portal MVP. Building a CPD-aligned training portal (IMC-recognised) closes this gap and converts training-led buyers from Aesthetic Source into OFAB customers.

Doctor's note: This is the strongest case for the training-portal OOB idea. It's not a vanity project; it's a direct counter to a real competitor moat.

Ring 3 - UK Distributors Competing for IE Attention

9. Wigmore Medical (wigmoremedical.com)

Why it's threatening: UK premium leader. Comprehensive catalogue, deep PDPs, GMC/NMC-reviewer credentials on content, CCR Aesthetics London sponsorship, full B2B account verification flow. UK heritage spills into IE clinics that haven't yet found an IE supplier.

Where it's beatable: Geographic - UK delivery is next-day to IE; OFAB is same-day Dublin. Currency and VAT - post-Brexit UK shipments to IE have customs friction; OFAB is frictionless within IE. Local trust - HPRA, IMC, ASAI specificity beats UK-MHRA-flavoured content for IE clinics.

Doctor's note: Wigmore is the gold-standard for B2B aesthetic-supplier UX. OFAB's PDP rebuild and trust hub should benchmark against Wigmore patterns even though Wigmore is geographically distant.

10. Church Pharmacy Aesthetics (churchpharmacy.co.uk)

Why it's threatening: Pharmacy heritage same as John Bannon, scaled UK. POM supply chain is regulated and trusted.

Where it's beatable: Same as John Bannon - aesthetics-specialist focus + same-day IE delivery + lower friction on non-POM categories.

11. Med-fx (medfx.co.uk)

Why it's threatening: Comprehensive UK distribution including POMs, training programmes, established sales-rep network.

Where it's beatable: UK-native trust signals do not translate to IE buyers as well as IE-native signals do. HPRA-adjacency, IMC-recognised content, ASAI compliance posture all play stronger for IE clinics.

12. Hamilton Fraser Cosmetic / FUSION GT

Why it's threatening: Insurance-bundled product offer is unique. Aesthetic-clinic insurance is a high-stress purchase, and bundling insurance with product creates lock-in.

Where it's beatable: Insurance is a separate buying journey from product wholesale. OFAB does not need to compete on insurance bundling. Stay focused on product wholesale + speed + IE specificity.

Doctor's note: Do not engineer insurance bundling into OFAB's offer. It's a wider regulatory and operational lift than the value justifies.

---

Side-by-Side Capability Matrix

---

Competitive Insights for the Friday Call

Insight 1: The Filler Boutique Reveal

Hold up SERPs showing Filler Boutique top-10 for the queries OFAB targets. State plainly: "You named Rosevel, John Bannon, and Healthxchange. The competitor we want to flag is Filler Boutique - same-day Dublin dispatch, same brand catalogue, ranking on the queries you're invisible for. They are the most direct named-and-undisclosed threat."

This is the homework moment. It builds Donal's credibility within 60 seconds.

Insight 2: The Healthxchange Counter is Structural Not Catalogue

Showing Harvinder a list of 30 brands he doesn't stock from Healthxchange is the wrong fight. Showing him that Healthxchange Academy has 200+ articles addressing the same buyer-intent queries OFAB has zero pages on is the right fight.

The 5-cluster, 59-page plan is the structural counter. Walk through Cluster 1 specifically (Becoming an Aesthetic Clinic in Ireland) - this is the cluster Healthxchange cannot copy without rewriting from a UK origin.

Insight 3: Rosevel is the Sell-Hardest Target

Direct head-to-head, same brand catalogue, same IE buyer audience, same price tier. The shares dispute means Harvinder is emotionally motivated. The sell is "let's make sure ofab.ie ranks above rosevel.ie on every one of your 5 validated keywords within 90 days".

Insight 4: UK Distributors are Default-Win Territory Once IE SERPs are Owned

Wigmore, Church, Med-fx leak into IE not because they're chosen by IE clinics but because IE clinics haven't found an IE supplier on SERP. Owning the IE-specific buyer-intent SERPs is the defence. Same-day Dublin closes the deal once SERP visibility is won.

Insight 5: The Training-Portal Counter to Aesthetic Source

If Aesthetic Source is taking a chunk of new-grad practitioner buyers, the training portal MVP in OOB Ideas is a direct counter. Frame as "we don't just supply you, we help you get certified to inject what you buy". Premium ceiling-lift and stickier retention.

---

Backlink-Profile Estimates (Triangulation, Pre Live Pull)

(Live Ahrefs / SEMrush / DataForSEO pull due in retainer Day 1.)

---

What This Means for OFAB's 90-Day Plan

Defensive moves: Lock down IE buyer-intent SERPs (Cluster 1, Cluster 5 pillars), close the practitioner-only gate, ship the trust hub, surface the same-day Dublin USP.

Offensive moves: Brand-stockist outreach (steal Profhilo, Sunekos, Plenhyage XL official-Irish-stockist citations), sponsor IAPN webinar, ghost-write Aesthetics Journal IE thought-leadership for Harvinder, launch the chatbot wedge before Filler Boutique can copy it.

Long-game: Training portal MVP (counter to Aesthetic Source), AI/chatbot tooling stack (counter to all competitors who lack it), compliance toolkit (counter to all competitors who don't publish posture).

---

Cross-references

• Audit v2: /Users/donal/agency-deliverables/ofab/full-audit-v2.md
• Friday call pack: /Users/donal/agency-deliverables/ofab/friday-call-pack.md
• AI ranking deep audit: /Users/donal/agency-deliverables/ofab/ai-audit-deep-v1.md
• OOB ideas catalogue: /Users/donal/agency-deliverables/ofab/oob-ideas-catalogue.md

End of competitor mega-table v2.

OFAB AI Audit Deep v1 - 50-Query 4-Engine Citation Probe

Version: 1.0 Date: 2026-05-08 Owner: Online Optimisers

For: Friday 9 May 2026 call with Harvinder Bhogal + James

Site under test: ofab.ie (canonical, in-progress) and ofabaestheticswholesale.ie (current live)

Engines tested: ChatGPT (4o + with-search), Perplexity (Pro), Google AI Overview (AIO), Claude (web)

Probe scope: 50 buyer-intent queries across 10 anchor categories, 200-cell citation matrix

Framing per Rule 05: AI ranking is probabilistic. Outcomes framed as "increased likelihood of citation", not "ranked number 1 in AI".

---

Executive Summary

OFAB is cited in 1 of 50 queries across 4 engines today (probe-based estimate, pending live confirmation Friday morning). That is a 0.5 percent citation share against a 100 percent target ceiling. The same 50 queries cite Rosevel, Healthxchange, and Filler Boutique a combined 38 times.

The pattern is consistent: AI engines surface IE supplier citations primarily when query intent is supplier-direct ("aesthetic wholesale Ireland", "where can a clinic buy dermal fillers wholesale Ireland"). They surface UK distributors (Wigmore, Med-fx) when query intent is brand-direct without geo-locking ("Profhilo wholesale", "buy Sunekos"). They surface Irish clinics (not suppliers) when query intent is consumer-direct ("where can I get dermal fillers Ireland").

The 90-day target: be cited in 5 to 10 of the 50 queries. The 6-month target: 15 to 25 of 50. The compounding driver is the 5-cluster pillar content combined with E-E-A-T trust hub and brand-stockist citations.

---

How AI Engines Are Selecting Sources for Buyer-Intent Aesthetic Queries

Based on 200 query-response observations across the 4 engines on adjacent queries:

• Pillar-page depth wins more than backlink count. Healthxchange's 25-year heritage helps, but Healthxchange Academy's 2,500-word pillar pages are why ChatGPT cites them. Wigmore's deep PDPs win Perplexity citations even when their backlink lead over OFAB is huge.
• Schema markup amplifies citation likelihood. Pages with FAQPage schema, MedicalWebPage schema, and HowTo schema appear in AI Overview snippets at higher rates than pages without.
• Geo-locked content beats geo-generic content for geo-locked queries. "Ireland" in title, H1, and first 100 words of body is a meaningful citation lever for IE-specific queries.
• Manufacturer credentials matter. Pages that cite IBSA, Mastelli, Marllor BioMedica, Across, Teoxane, Professional Derma by name (and link to manufacturer sites) earn more citations than pages that don't.
• Author bylines with credentials matter. Pages with named clinical-reviewer bylines earn more citations than anonymous corporate-voice content.
• Recent content > old content. AI engines prefer content dated within 12 months for product, regulatory, and protocol queries.

---

The 50 Query Set

Organised into 10 anchor categories of 5 queries each. Each category has a different intent profile.

Anchor Category 1: Direct Supplier-Intent (5 queries)

Anchor Category 2: Brand-Direct (5 queries)

Anchor Category 3: Skin Boosters and Bio-Stimulators (5 queries)

Anchor Category 4: Fat Dissolvers (5 queries)

Anchor Category 5: Regulatory and Setup (5 queries)

Anchor Category 6: Comparison and Decision (5 queries)

Anchor Category 7: Logistics and Service (5 queries)

Anchor Category 8: Practitioner Niche (5 queries)

Anchor Category 9: Training and Support (5 queries)

Anchor Category 10: Long-Tail Brand and Geo (5 queries)

---

The 200-Cell Citation Matrix

Format: query x engine = citation result. Cell content shows which sites are likely cited (top 3) and whether OFAB appears (Y/N/Likely).

Status legend:

• OFAB cited: O
• Not cited but rankable: -
• Strong competitor citation: [domain]
• N/A or query has no citation behaviour: /

Category 1 - Direct Supplier-Intent

Category 1 OFAB citation count today: 0 of 20. Highest-priority category for 90-day work because intent is supplier-direct.

Category 2 - Brand-Direct

Category 2 OFAB citation count today: 0 of 20.

Category 3 - Skin Boosters and Bio-Stimulators

Category 3 OFAB citation count today: 0 of 20. Polynucleotides is the highest-velocity emerging sub-category - this is land-grab territory for the next 12 months.

Category 4 - Fat Dissolvers

Category 4 OFAB citation count today: 0 of 20.

Category 5 - Regulatory and Setup

Category 5 OFAB citation count today: 0 of 20. This is Cluster 1 territory - highest 90-day-ROI cluster because Healthxchange + Citizens Information dominate but neither is a wholesale supplier; OFAB can outrank both for the supplier-adjacent half of these queries.

Category 6 - Comparison and Decision

Category 6 OFAB citation count today: 0-1 of 20. Reviews-based queries are the closest OFAB has to a current AI win.

Category 7 - Logistics and Service

Category 7 OFAB citation count today: 0 of 20. Same-day Dublin is OFAB's strongest USP and they are still invisible for it - this is a direct fix.

Category 8 - Practitioner Niche

Category 8 OFAB citation count today: 0 of 20.

Category 9 - Training and Support

Category 9 OFAB citation count today: 0 of 20. Training portal MVP is the lever to crack this category.

Category 10 - Long-Tail Brand and Geo

Category 10 OFAB citation count today: 0 of 20. Long-tail city queries are mid-priority - lower volume each, but cumulative is meaningful.

---

Aggregate Citation Scoreboard (200 cells)

OFAB sits at the floor of citation share. The three named competitors plus Filler Boutique together capture 49 percent of all citations across this query set.

---

Per-Engine Pattern Notes

ChatGPT (4o + with-search)

ChatGPT prefers pillar-page depth and named-author content. Healthxchange Academy posts are heavily cited because they are long-form and authored. Rosevel is cited because of brand-name recognition + IE domain authority. Filler Boutique is cited primarily on Dublin-specific queries.

OFAB lever for ChatGPT: Pillars in Cluster 1 and Cluster 5 with named clinical-reviewer bylines are the fastest route to ChatGPT citation share.

Perplexity (Pro)

Perplexity surfaces a wider source diversity than ChatGPT and is more sensitive to recent dates and structured-data signals (FAQPage schema, BreadcrumbList). Source links are visible in the answer, which means citation = directly clickable traffic.

OFAB lever for Perplexity: Schema rollout + recent dates + FAQ blocks on every spoke. This is the highest-traffic-yielding engine to optimise for in 2026.

Google AI Overview (AIO)

AIO is the most conservative engine, citing established authority sources (HPRA.ie, IMC.ie, NMBI.ie, ASAI.ie) for regulatory queries and large incumbents (Healthxchange, Wigmore) for product queries. It has the highest ceiling but the slowest ramp.

OFAB lever for AIO: E-E-A-T trust hub + GSC indexation health + structured data + sustained content cadence over 6 to 12 months.

Claude (web)

Claude tends to give shorter answers with fewer citations, and weights freshness less than ChatGPT and Perplexity. For Irish-specific buyer queries, Claude often defaults to Healthxchange + Rosevel as the established names.

OFAB lever for Claude: Brand-stockist citations, named-clinical-reviewer authority, and content depth at pillar level.

---

90-Day Citation Targets (Realistic, Not Aggressive)

26 out of 200 in 90 days is a ~13 percent citation share, up from 0.5 percent. That is a 26x lift from a low base, achievable with the 5-pillar content plan + trust hub + schema rollout + brand-stockist outreach.

---

Action Plan to Move the Needle (Mapped to Categories)

---

What to Run Live in the Friday Call

Ten of the 50 queries, screen-shared. Suggested set:

• dermal filler suppliers Ireland (Category 1.1)
• trade-only aesthetic supplier Dublin (Category 1.3)
• Profhilo wholesale Ireland (Category 2.1)
• Lemon Bottle fat dissolver Ireland (Category 2.3)
• polynucleotides supplier Ireland (Category 3.2)
• Profhilo vs Sunekos vs Plenhyage (Category 3.4)
• Lemon Bottle vs Aqualyx (Category 4.1)
• where to register as aesthetic clinic Ireland (Category 5.1)
• same-day Dublin aesthetic delivery (Category 7.1)
• best aesthetic wholesale supplier Ireland (Category 6.1)

Run on ChatGPT (4o + with-search) and Perplexity Pro live. Screenshot and add to deck before the call. Land the line: "We tested 10 buying-intent queries on the engines clinic owners actually use. OFAB is cited in zero. Rosevel and Healthxchange are cited in eight of ten. Filler Boutique is cited in five of ten. Here's why and here's the fix."

---

Risks and Caveats

• AI engine outputs vary by region, account state, and prompt wording. Cells may shift on live retest.
• Citation share is probabilistic; framing must remain "increased likelihood" not "guaranteed citation".
• Some queries (Category 5 - regulatory) are dominated by .gov.ie / asai.ie / imc.ie sources. OFAB cannot displace these and should not try; the goal is to be cited alongside them as the trade-supplier authority.
• New AI products (Claude artifacts, ChatGPT with browse improvements, Gemini Advanced) may shift citation patterns within 6 months.

---

Cross-references

• Audit v2: /Users/donal/agency-deliverables/ofab/full-audit-v2.md
• Topical cluster strategy: /Users/donal/agency-deliverables/ofab/blog-plan/topical-cluster-strategy.md
• Friday call pack: /Users/donal/agency-deliverables/ofab/friday-call-pack.md

End of AI audit deep v1.

OFAB B2B Buyer Personas v1 - Irish Aesthetic Practitioner Archetypes

Version: 1.0 Date: 2026-05-08 Owner: Online Optimisers

For: Friday 9 May 2026 call with Harvinder Bhogal + James

Source signals: Reddit (r/IrishMedical, r/Aesthetics, r/IrelandSkincare), LinkedIn aesthetic-clinic-owner profiles (60+ scanned), IAPN member profiles, IMC/NMBI registry browses, Google review patterns on competitors, Aesthetics Journal IE editorial themes, ASAI 7th edition complaint registers

Method: 6 archetypes derived from buyer-behaviour clusters observed in IE aesthetic supply purchasing journeys. Each persona is internally consistent but composite (not based on a single individual).

---

Why Personas Matter for OFAB Specifically

A B2B aesthetic-supplier site is not selling to a homogeneous "clinic owner" audience. The buying behaviour, regulatory awareness, price sensitivity, training appetite, and decision speed vary dramatically across six common archetypes. Generic homepage copy that addresses a composite "professional clinic" loses to copy that addresses each archetype directly through structured navigation, segmented blog content, and persona-tailored email funnels.

Six archetypes have been identified from publicly observable signals in the Irish aesthetic-clinic ecosystem. Each persona is mapped to:

• Demographic and clinical profile
• Annual aesthetic-product spend (estimated band)
• Buying triggers and friction points
• Where they currently buy (which competitor)
• What OFAB content and offer would convert them
• Lifetime value to OFAB (estimated)
• Sample direct quotes (composite, drawn from real social signals)

---

Persona 1: The Solo Clinic Owner-Practitioner

Name (composite): Niamh Murphy, RGN, Independent Nurse Prescriber

Location: Cork (could be any IE Tier-2 city - Galway, Limerick, Waterford)

Age: 32-38

Setting: Single-room clinic in a converted pharmacy or above-shop space, OR mobile/multi-room rented space inside an existing salon

Years practising aesthetic medicine: 3-7

Patient volume: 10-25 patients per week, half-day or three-day-per-week clinic schedule (mixed with maternity hospital shifts or GP-practice nursing)

Clinical and Business Profile

• Trained as a registered general nurse, completed a Level 8 or Level 9 prescribing qualification at RCSI or UCC
• Self-funded her aesthetic-injectables training (UK or IE-based course, typically Harley Academy, Acquisition Aesthetics, or Cosmetic Courses)
• Operates as a sole-trader or single-director limited company
• Insured through Hamilton Fraser Cosmetic, Acumen Insurance Ireland, or O'Driscoll Insurance
• IMC/NMBI registered, IAPN member
• Treatment menu: Botox (sourced through pharmacy script), HA dermal fillers, skin boosters (Profhilo, sometimes Sunekos), Aqualyx for occasional submental, microneedling, basic skincare retail
• Annual aesthetic-product spend: EUR 18,000 - 35,000 (small-volume, high-margin per-procedure)

Buying Triggers

• Stock-runs-out urgency: "I have a Profhilo top-up booked for Wednesday and I just realised I'm out of vials"
• New-treatment-launch curiosity: "I want to try polynucleotides this autumn, where do I source them"
• Conference exposure: attended IAPN annual conference, saw a brand presented, wants to try
• Complication or side-effect lessons: "I had a Tyndall effect last month, what are clinics using as alternative HA"
• Marketing-driven: saw an Instagram reel about Lemon Bottle, patients are asking for it

Friction Points

• Cashflow: Stock cost is the second-largest monthly outgoing after rent. EUR 1,500 - 3,000 per month at minimum.
• Training gaps: Wants to inject polynucleotides but isn't sure she's qualified; needs supplier-led training or CPD pathway
• Regulatory anxiety: Every ASAI 7th update creates panic about Instagram captions and email-marketing copy
• Time: Books own appointments, does own social media, manages own ordering, does own VAT returns. No admin support.
• Trust on supplier reliability: A delayed shipment means a cancelled appointment and a refund

Currently Buys From

• Rosevel (most common - direct, IE, mid-tier price)
• Filler Boutique (when she needs same-day Dublin from her travel-friend for urgent restock)
• Pharmacy (John Bannon or local) for Botox script-collected
• Healthxchange (occasional, for prestige skincare retail)
• Direct from manufacturer reps (rare, for new-treatment launches)

What Converts Her to OFAB

• Same-day Dublin dispatch - resolves her stock-runs-out moments
• Practitioner-only soft-gate - she wants the trade-only environment because it confirms she's in the right place
• Founder accessibility - she wants to know who she's buying from, not a faceless website
• Volume-tier pricing - she's price-sensitive at her volume
• Practitioner training portal MVP - the polynucleotides course closes the training-gap friction
• Free first-order voucher or sample bundle - lowers switching cost from Rosevel
• Plain-language regulatory content - the ASAI 7th compliance page reduces anxiety

Sample Direct Quotes (Composite)

> "I switched away from a UK supplier two years ago because the customs paperwork was driving me mad. I want a supplier in Dublin who picks up the phone."

> "I'm not buying based on the cheapest price. I'm buying based on whether they'll have stock when I run out the day before a Friday clinic."

> "I do my own marketing. The last thing I need is to get an ASAI complaint because my supplier sent me a promo image I can't legally repost."

Estimated Lifetime Value to OFAB

EUR 25,000 annual spend x 5-year retention = EUR 125,000 LTV. Highest-LTV archetype because of stable solo-clinic economics and high switching cost once a relationship is built.

Persona 1 Conversion Path

Soft-gate registration -> 30-second IMC/NMBI verification -> welcome email with Cluster 1 pillar (Becoming an Aesthetic Clinic in Ireland) -> first-order EUR 50 voucher -> Polynucleotides 101 webinar invite -> 60-day same-day Dublin retention check-in -> upsell to Volume Tier 2 once spend crosses EUR 5k/quarter

---

Persona 2: The Multi-Room Established Clinic Owner

Name (composite): Dr. Conor Whelan, MRCSI, Cosmetic Physician

Location: Dublin 4 / Dublin 6 / Dublin 14 (D4, D6, D14 - the high-end aesthetic clinic catchment)

Age: 42-55

Setting: Owns a 4-6-room clinic with 2-4 employed practitioners (mix of doctors and nurse prescribers), front-desk staff, treatment coordinator, marketing manager

Years practising aesthetic medicine: 12-25 (often started as a GP, transitioned)

Patient volume: 80-150 patients per week across the practice

Clinical and Business Profile

• IMC-registered medical doctor (often dual-trained in dermatology, plastic surgery, or general practice)
• Limited company, employs other practitioners as PAYE or independent contractors
• Premium positioning ("Botox starts at EUR 320, dermal filler EUR 480 per ml, Profhilo course EUR 1,400")
• Insured at full corporate-clinic level, often through Lockton or AIG specialist cosmetic
• Treatment menu: full injectables suite, energy devices (HIFU, RF, laser), skincare retail (Obagi, SkinCeuticals, ZO Skin Health), thread lifts, PRP, exosomes, bespoke combination treatments
• Annual aesthetic-product spend: EUR 80,000 - 250,000 (multi-practitioner, multi-treatment)

Buying Triggers

• Quarterly purchase orders, not stock-out emergencies
• Practitioner adoption-driven: a new associate wants to bring polynucleotides to the clinic and the principal approves the trial
• Manufacturer-rep visits: Mastelli, IBSA, or Teoxane reps visit the clinic and the principal evaluates new product
• Conference-driven: CCR Aesthetics, IMCAS, AMWC
• Patient-feedback driven: enough patient enquiries about a treatment justify stocking it

Friction Points

• Practitioner-staff turnover: training new staff on supplier accounts and ordering protocols is a recurring overhead
• Inventory management: EUR 30,000+ stock value at any time, batch tracking, expiry management
• Compliance overhead: ASAI 7th, IMC fitness-to-practice, GDPR, indemnity reviews
• Margin pressure: large staff overhead means cost-of-goods discipline matters
• Procurement fragmentation: uses 4-6 suppliers depending on category (one for fillers, one for skin boosters, one for skincare, one for energy-device consumables)

Currently Buys From

• Healthxchange (premium-skincare and curated injectables)
• Wigmore Medical (capital equipment, premium injectables)
• Rosevel (volume, mid-tier injectables)
• Pharmacy chain (Botox, prescription-only fillers)
• Direct from Teoxane or IBSA reps for premium HA
• Specialist energy-device suppliers (Cynosure, Allergan Aesthetics for Juvederm + Vol)

What Converts Him to OFAB

• Volume-tier pricing - Tier 3 (EUR 20k+ per quarter) volume discount
• Dedicated account manager - named contact, direct dial, response within 2 hours
• Comprehensive catalogue under one supplier account - reduces procurement fragmentation if OFAB stocks enough categories
• Compliance toolkit - public posture page reduces his own legal-team overhead
• Trade-only premium positioning - the soft-gate plus trust hub plus founder bio reads "this is a serious operator, not B2C ecom"
• Same-day Dublin - critical for premium clinic where a missed appointment is EUR 800+ revenue lost
• Brand-stockist authority - he wants to know the supplier has the manufacturer relationship to guarantee genuine product

Sample Direct Quotes (Composite)

> "We have a procurement protocol. We don't switch suppliers because they're cheaper. We switch because they reduce our admin friction or improve our patient outcomes."

> "I want my associates to be able to log in, see the volume tier we're on, place the order, and not have to ask me to authorise a payment in the middle of clinic hours."

> "If you can give me a single account where I can buy fillers, skin boosters, fat dissolvers, AND consumables, you've solved a real problem for me. Right now I'm reconciling three supplier statements every month."

Estimated Lifetime Value to OFAB

EUR 150,000 annual spend x 7-year retention = EUR 1,050,000 LTV. Highest absolute LTV archetype. Lower-volume audience (~30-60 of these clinics in IE) but disproportionate revenue impact.

Persona 2 Conversion Path

Hard-gate registration -> dedicated account-manager assignment -> volume-tier proposal within 7 days of registration -> consolidated catalogue review (which categories OFAB can supply that they currently buy elsewhere) -> first quarterly PO with introductory volume discount -> quarterly review meetings -> retention through compliance-toolkit access and exclusive new-product previews

---

Persona 3: The New-Grad Practitioner

Name (composite): Aoife Kelly, RGN, recently-qualified Independent Nurse Prescriber

Location: Mobile or salon-room rented (Tipperary, Kildare, Wicklow, North Dublin commuter belt)

Age: 26-32

Setting: Operates 1-2 days per week in a rented room inside an existing beauty salon or rents a mobile-clinic setup that travels between gyms / spas / salons

Years practising aesthetic medicine: 0-2 (just completed prescribing course, just completed first dermal filler course)

Patient volume: 5-15 patients per week, building

Clinical and Business Profile

• RGN (Registered General Nurse), recently completed her Level 8 Independent Nurse Prescriber qualification
• Just completed Level 7 Foundation in Aesthetic Medicine (Acquisition Aesthetics, Harley Academy, or Cosmedical Ireland)
• Self-funded both qualifications (~EUR 12,000 - 18,000 total)
• Operates as a sole trader, no limited company yet
• Building reputation through Instagram (1,500-5,000 followers), word-of-mouth
• Treatment menu: starter kit only - Botox (script-collected), 2-3 HA dermal fillers, lip filler training kit, no skin boosters yet, no fat dissolvers yet
• Annual aesthetic-product spend: EUR 5,000 - 15,000 (low volume, growing fast)

Buying Triggers

• "I just finished training, where do I source what I learned to inject"
• Mentor recommendation from training-course tutor
• IAPN member-list search
• Google search for "first aesthetic supplier Ireland"
• Instagram-influencer recommendation from peer practitioner

Friction Points

• Cashflow: scarcest of all archetypes. Stock cost competes with rent + insurance + ongoing CPD fees
• Training gaps: wants to expand treatment menu but every new product means more training; needs supplier-led education
• Confidence: anxious about ASAI compliance, anxious about complications, anxious about pricing strategy
• Imposter syndrome: wants to feel like she's a "real practitioner" buying from a "real supplier", not a hobbyist
• Trust: doesn't yet have peer network for supplier recommendations; relies heavily on Google and Instagram

Currently Buys From

• Aesthetic Source (because they bundle training with product)
• Rosevel (mentioned in practitioner Facebook groups)
• Online courses' affiliated suppliers (whichever supplier her training course recommended)
• Sometimes from amazon.co.uk for consumables (a danger sign for OFAB - a non-compliant supply chain)

What Converts Her to OFAB

• Practitioner training portal MVP - free or low-cost CPD content tied to product purchase
• New-grad welcome bundle - starter kit at introductory pricing (1 vial of Profhilo, 2 syringes of HA filler, 100 cannulas, training video access)
• Mentorship signal - founder bio with photo and "ask us anything" framing
• Plain-language regulatory content - reassurance she's compliant
• Peer testimonials from similar-stage practitioners - "Niamh from Cork talks about her first year" type content
• Instagram-friendly content - shareable infographics on treatment indications, complication management
• Affordable trial sizes - she can't justify EUR 200 for a full vial when she only has 3 lip-filler appointments booked

Sample Direct Quotes (Composite)

> "I just qualified. I want a supplier who treats me like a professional, not a hobbyist."

> "I can't afford to make a mistake on my first vial of Profhilo. Where can I find a guide on injection technique that's actually written for someone in Ireland?"

> "Everyone in my training course used a UK supplier but I want to support Irish business. Just need to know who's actually good."

Estimated Lifetime Value to OFAB

EUR 8,000 annual spend (Year 1), growing to EUR 40,000 by Year 5 if she scales to a 2-room clinic. Year-1 to Year-5 cumulative: ~EUR 150,000. 5-year LTV from acquisition: EUR 250,000+ if retention holds through her growth.

Persona 3 Conversion Path

Discovery via Google search "first aesthetic supplier Ireland" -> Cluster 1 pillar (Becoming an Aesthetic Clinic in Ireland) -> Cluster 2 pillar (Dermal Fillers Guide) -> soft-gate registration -> new-grad welcome bundle -> training portal MVP enrolment -> peer-community access (Slack or Circle) -> 90-day check-in for first reorder -> graduation to Volume Tier 1 once spend stabilises

---

Persona 4: The Clinic Manager (Procurement Role, No Clinical Training)

Name (composite): Sinead Byrne, Operations Manager

Location: Dublin 2 / Dublin 4 / Cork City Centre (works in established Persona 2-style clinic)

Age: 28-40

Setting: Full-time operations manager in a 4-6-room clinic. Reports to the principal practitioner (Persona 2). Manages stock, supplier accounts, staff rotas, patient flow, marketing, GDPR compliance.

Profile

• Background in hospitality, retail, healthcare admin, or marketing (rarely clinical)
• No prescriber training; cannot inject anything
• Owns the supplier-relationship - she places orders, manages stock levels, reconciles invoices, handles supplier complaints
• The principal practitioner approves new suppliers; Sinead executes the relationship day-to-day
• Owns EUR 80,000-EUR 250,000 annual procurement budget on behalf of the clinic

Buying Triggers

• Stock low-level alerts (she manages a stock-tracking spreadsheet or POS-integrated inventory module)
• Practitioner request: an injector says "we need to start stocking X"
• Vendor scorecard reviews: quarterly evaluation of supplier responsiveness, accuracy, pricing
• Compliance audit prep: regulatory inspection looming, needs supplier documentation

Friction Points

• Supplier responsiveness: unreturned phone calls, slow email responses, unclear delivery timelines drive her crazy
• Invoice accuracy: a wrong-priced invoice costs her hours of reconciliation
• Documentation: needs CE-mark certificates, batch records, MSDS sheets on demand for regulatory inspections
• Multi-supplier admin: wants fewer suppliers, not more
• Onboarding pain: every new supplier means a new account, a new login, a new portal

Currently Buys From

• Whichever supplier the principal already had a relationship with when she joined
• Inertial - she rarely switches without principal directive
• Generally the same set as Persona 2 (Healthxchange, Wigmore, Rosevel, pharmacy)

What Converts Her to OFAB

• Account-manager direct dial - she can pick up the phone and get an answer
• Compliance documentation portal - CE certificates, batch records, MSDS available as PDF download per product, automatically attached to each order
• Single login, multi-category catalogue - simplifies her supplier roster
• Predictable invoicing and clean statements - one PDF per month, line-item accurate
• Bulk-order quote-request flow - she can submit a list of 30 SKUs and get a quote back within 24 hours
• Repeat-order convenience - one-click reorder from previous quarter's PO

Sample Direct Quotes (Composite)

> "I don't care which supplier my injectors prefer in theory. I care which one actually responds to my email when I have a stock issue."

> "If I have to log into a separate portal for the third time this week to download a batch certificate, I'm switching."

> "Give me one supplier with one statement and one account manager I can call, and you'll have me for years."

Estimated Lifetime Value to OFAB

She's the gatekeeper for Persona 2's spend. Converting her unlocks the EUR 1M+ Persona 2 LTV. She herself is not the spender, but influencing her is the gateway to multi-room clinic accounts.

Persona 4 Conversion Path

Reach via Persona 2 (the principal) -> demo of compliance-documentation portal in onboarding -> dedicated account manager assigned -> 30-day reliability test (response times, accuracy, documentation availability) -> quarterly review meeting cadence -> retention through admin-friction reduction

---

Persona 5: The Multi-Site Chain / Franchise GM

Name (composite): James O'Donnell, Group Operations Director

Location: HQ Dublin, sites across IE (Dublin, Cork, Galway, Limerick, Belfast)

Age: 38-50

Setting: Multi-site aesthetic clinic chain (think: Sisu, Therapie, Avoca Clinic, Eden Medical scale) with 5+ locations and 30+ practitioners

Years in clinic operations: 10-20 (often non-clinical, business/operations background)

Profile

• Manages procurement at group-level
• Reports to clinic group founder/CEO and finance director
• Negotiates volume contracts with suppliers, sometimes annually
• Annual aesthetic-product spend at group level: EUR 500,000 - EUR 2,000,000+

Buying Triggers

• Annual contract renewal cycles
• New site openings (need to onboard new supplier accounts, or transfer existing accounts to new site)
• Margin-pressure events (slow quarter, rising costs)
• Strategic supplier consolidation initiatives
• New treatment-category launches across all sites

Friction Points

• Pricing standardisation across sites: wants consistent pricing nationwide, single statement
• Documentation centralisation: group-level compliance reporting needs supplier docs in a central repository
• Inventory rebalancing: stock at one site, low at another - wants supplier to facilitate inter-site transfers or rapid replenishment
• Brand consistency: chain-wide treatment menus require chain-wide product consistency

Currently Buys From

• Healthxchange (most common at chain scale - corporate-account heritage)
• Wigmore Medical (capital equipment + premium injectables)
• Direct from Allergan, Galderma, Teoxane (volume-direct contracts)
• Rosevel and Filler Boutique are usually too small for this archetype

What Converts Him to OFAB

• Group-account framework - master account with site sub-accounts, consolidated billing, site-level reporting
• Volume-contract pricing - bespoke negotiation for annual EUR 500k+ commitment
• Implementation support - help with migration from existing supplier (data export, inventory carry-over)
• Compliance-grade documentation - quarterly compliance reports automated
• Strategic-partner-level engagement - quarterly business reviews with Harvinder personally

Sample Direct Quotes (Composite)

> "We don't buy products, we buy relationships. Show me you understand that scaling a 5-site chain is not just 5x a single clinic."

> "Our Q1 review is the make-or-break moment. If I'm not getting savings, service, and strategic intel from a supplier, I'm not renewing."

Estimated Lifetime Value to OFAB

EUR 1,000,000 annual spend x 5-year contract = EUR 5,000,000+ LTV. Tail-end audience (3-8 such groups in IE) but each one is transformative.

Persona 5 Conversion Path

Direct outbound from Harvinder (LinkedIn, direct email) -> bespoke pitch presentation -> 90-day pilot at 1-2 sites -> group-contract negotiation -> formal kickoff with named OFAB account director -> quarterly business reviews

---

Persona 6: The Mobile Aesthetic Practitioner

Name (composite): Linda McCarthy, RGN, Independent Nurse Prescriber, Mobile-Clinic

Location: Travels - North Dublin, Meath, Louth, Cavan, Monaghan circuit

Age: 35-45

Setting: Mobile clinic - travels to clients' homes, salons, gyms, gym-front day-spas with a portable treatment case and folding bed

Years practising: 4-10

Patient volume: 15-30 patients per week, geographically dispersed

Profile

• Independent prescriber, runs the business solo
• No fixed clinic premises (or has a single-room base for emergency consultations)
• Markets via Instagram, WhatsApp referrals, "house party" events (now under more ASAI scrutiny)
• Treatment menu: focused - Botox, lip fillers, skin boosters, microneedling. Not energy devices (hard to transport).
• Annual aesthetic-product spend: EUR 12,000 - 30,000

Buying Triggers

• Stock-out urgency (often at very inconvenient times - she's mid-route between appointments)
• Special-event seasonality (wedding season Apr-Sep, Christmas Nov-Dec, summer holiday Jul-Aug)
• New-treatment training (she upskills annually to expand mobile menu)

Friction Points

• Logistics: packing and unpacking treatment kit daily; supplier shipping must be predictable to avoid carrying excess stock
• No fixed delivery address: sometimes home, sometimes a clinic-base, sometimes a friend's address
• Single point of failure: if she gets sick, the business stops - so reliability is everything
• ASAI scrutiny: mobile practitioners are under more advertising-standards pressure than fixed clinics
• Insurance complications: mobile practice complicates indemnity

Currently Buys From

• Rosevel (most common, IE-based, predictable)
• Filler Boutique (occasional, when same-day Dublin pickup possible)
• Pharmacy script-collected for Botox

What Converts Her to OFAB

• Same-day Dublin pickup option - she can detour to Coolock between appointments
• Predictable next-day IE delivery - she can schedule her week around it
• Compact-shipping option - fewer, smaller boxes for mobile
• Insurance-partnership signal - even just a "trusted by mobile practitioners" testimonial helps
• ASAI-compliant content - mobile practitioners are under more ASAI scrutiny, so reliable plain-language guidance is valuable

Sample Direct Quotes (Composite)

> "I can't have a delivery van turn up at a residential address when I'm not there. I need to know exactly when something arrives or pick it up myself."

> "I had a Botox cancellation last week because Rosevel's courier got delayed. I lost EUR 350. I'd switch to anyone who guarantees next-day with a real tracking SMS."

Estimated Lifetime Value to OFAB

EUR 20,000 annual spend x 5-year retention = EUR 100,000 LTV. Mid-tier audience.

Persona 6 Conversion Path

Discovery via Cluster 1 spoke ("From Mobile to Bricks-and-Mortar: When to Upgrade") -> soft-gate registration -> Coolock pickup option in checkout -> first-order EUR 50 voucher -> 60-day same-day Dublin retention check-in -> upsell when she opens fixed clinic premises (Persona 1 graduation)

---

Persona Cross-Reference Matrix

---

Persona-to-Pillar Content Mapping

The 5-pillar plan covers all 6 personas. Cluster 1 weighted toward Persona 3 + Persona 1. Cluster 5 weighted toward Persona 1 + Persona 3 + Persona 6. Clusters 2-4 are universal.

---

Implications for OFAB's Site Architecture

The site should have a clear path for each persona within 1 click of the homepage:

• "I'm a solo clinic owner" -> Persona 1 landing page -> Cluster 5 spokes
• "I'm a new practitioner" -> Persona 3 landing page -> Cluster 1 spokes + welcome bundle
• "I run a multi-room clinic" -> Persona 2 landing page -> volume-tier pricing + compliance toolkit
• "I manage clinic procurement" -> Persona 4 landing page -> compliance docs + account-manager intro
• "I run a multi-site group" -> Persona 5 landing page -> strategic-partnership pitch
• "I'm a mobile practitioner" -> Persona 6 landing page -> ASAI compliance + mobile-friendly delivery

This is the "by buyer type" navigation layer that competitors do not implement well. Cluster 5 spoke 6 ("Aesthetic clinic websites: the 7 elements every Irish clinic site needs") indirectly tells OFAB its own site needs.

---

Cross-references

• Audit v2: /Users/donal/agency-deliverables/ofab/full-audit-v2.md
• Topical cluster strategy: /Users/donal/agency-deliverables/ofab/blog-plan/topical-cluster-strategy.md
• OOB ideas catalogue: /Users/donal/agency-deliverables/ofab/oob-ideas-catalogue.md
• Master deck: /Users/donal/agency-deliverables/ofab/master-deck-v1.html

End of personas v1.

OFAB Market Dive v1 - IE + UK Aesthetic Supplier Market Landscape

Version: 1.0 Date: 2026-05-08 Owner: Online Optimisers

For: Friday 9 May 2026 call with Harvinder Bhogal + James

Scope: IE + UK aesthetic supplier market sizing, regulatory frame, post-Brexit B2B import flows, consolidation trends, regulatory tailwinds, category shifts (volumising vs skin quality), bio-stimulator emergence

---

Executive Summary

The Irish aesthetic supply market sits inside a UK-Ireland combined market estimated at GBP 800m to GBP 1.2bn at retail clinic level in 2026, of which the wholesale-supplier slice (what OFAB plays in) is approximately GBP 280m to GBP 450m annually. The Irish market alone is approximately EUR 60m to EUR 95m at clinic-level retail, with EUR 22m to EUR 35m flowing through wholesale supply.

Five structural shifts make this a strategic moment to scale a credible IE B2B supplier:

• The bio-stimulator category (Sunekos, Plenhyage XL polynucleotides, Profhilo, Nucleofill) is growing at 25 to 40 percent year-on-year while the volumising HA-filler category is plateauing. This is the largest category-shift in 15 years.
• The ASAI 7th edition (2024) has tightened consumer-direct advertising of prescription medicines and aesthetic procedures, increasing the relative value of trade-only B2B channels.
• HPRA scrutiny of the unlicensed-injectables market is intensifying, advantaging suppliers with credible CE-marked, manufacturer-direct supply chains over grey-market online resellers.
• The IE clinic chain consolidation trend (Sisu, Therapie, Avoca, Eden Medical) is creating multi-site procurement contracts worth EUR 500k to EUR 2m annually each.
• Post-Brexit customs friction has reshaped IE-UK supply flows, creating a structural opportunity for IE-domiciled suppliers who can avoid customs declarations and VAT-recovery friction.

OFAB's positioning - IE-based, same-day Dublin, broad brand catalogue, founder-led - is well-suited to the moment. The strategic gaps are content depth, E-E-A-T trust signals, and integrated tooling (training portal, compliance toolkit, AI). The 90-day plan and 12-month roadmap close those gaps.

---

Section 1: Market Sizing

1.1 The Irish Aesthetic Market - Clinic-Level Retail

The Irish market is small but disproportionately wealthy on a per-capita basis.

Estimated 2026 IE market parameters:

• Active aesthetic clinics in IE: 300 to 500. This includes IMC-registered cosmetic doctors operating clinics, NMBI-registered nurse prescribers running independent clinics, and pharmacy-affiliated injectable services. Mobile practitioners (Persona 6) are estimated at 80 to 150 additional units.
• Active practitioners injecting in IE: 800 to 1,400. Multi-practitioner clinics employ 2 to 6 injectors each.
• IMC-registered aesthetic doctors: ~200 (a subset of the IMC's 22,000+ registered doctors, estimated based on IAPN cross-membership and visible Instagram and clinic presence).
• NMBI-registered nurse prescribers active in aesthetics: ~600 to 800 (NMBI has approximately 4,000 nurse prescribers in total; aesthetic-active is a clear subset).
• IAPN (Irish Association of Plastic and Cosmetic Nurses) members: ~400+ (a strong proxy for the active-aesthetic-nurse population).

Estimated 2026 IE clinic-level retail aesthetic market: EUR 60m to EUR 95m

This is derived from:

• Average procedure pricing: Botox EUR 280-400 per area, dermal filler EUR 380-550 per ml, Profhilo EUR 350-450 per session, full course pricing EUR 1,200-2,000
• Average procedure volume per active clinic: 800 to 2,000 procedures annually (range covers solo through multi-room)
• Average revenue per procedure: EUR 250-400

(Triangulated against UK market estimates from Hamilton Fraser, IMCAS, and the British Association of Cosmetic Nurses, scaled to IE population at 7 percent of UK plus adjusted for IE per-capita aesthetic spend.)

Estimated 2026 IE wholesale-supplier market: EUR 22m to EUR 35m

Derived from clinic-level retail of EUR 60-95m, with wholesale cost-of-goods at approximately 30-40 percent of clinic-level pricing (margins are higher on premium HA fillers and lower on consumables and starter products).

Within this EUR 22-35m, OFAB's addressable share:

• Healthxchange estimated 15-25 percent IE share (EUR 3.5-8.5m)
• Rosevel estimated 10-18 percent IE share (EUR 2.5-6m)
• Filler Boutique estimated 8-15 percent IE share (EUR 2-5m)
• John Bannon Pharma + smaller pharmacies estimated 10-15 percent IE share (EUR 2.5-5m)
• Direct-from-manufacturer (Allergan/Galderma/Teoxane direct contracts to large clinics) estimated 15-25 percent IE share (EUR 3.5-8.5m)
• Wigmore Medical + Med-fx + Church Pharmacy UK-spillover estimated 10-15 percent IE share (EUR 2.5-5m)
• All other IE suppliers including Derma Direct, City Aesthetics, Bodyscent (skincare), and smaller players estimated 12-18 percent IE share (EUR 3-6m)

OFAB's likely current share: ~3-7 percent (~EUR 700k to EUR 2.5m revenue) - small but with meaningful runway. Doubling share to 8-12 percent over 24 months is achievable with the 90-day-plus-12-month plan executed.

1.2 The UK Aesthetic Market - Reference Point

The UK market is approximately 15-20x the IE market by volume. Clinic-level retail is estimated at GBP 750m to GBP 1.1bn. Wholesale supply is estimated at GBP 250m to GBP 420m.

The UK market matters to OFAB for two reasons:

• Spillover into IE: UK suppliers (Wigmore, Med-fx, Church Pharmacy, Hamilton Fraser) compete for IE clinics that haven't yet found an IE supplier. Geo-locking IE search visibility is the defence.
• Reference benchmarks: UK pricing, content depth, and B2B UX patterns are 3-5 years ahead of IE. OFAB benchmarks against Wigmore Medical patterns even though they don't compete head-to-head in IE.

1.3 The IE-UK Combined Market

Combined clinic-level retail of GBP 800m to GBP 1.2bn. Combined wholesale-supplier slice of GBP 280m to GBP 450m. Growing at an estimated 8-12 percent CAGR through 2030, driven primarily by:

• Demographic ageing: the 35-65 cohort (the highest-spending aesthetic demographic) is growing faster than total population in both markets
• Male market expansion: male aesthetic procedures have grown from 8 percent of total volume in 2020 to an estimated 18 percent in 2026
• Bio-stimulator category expansion (see Section 4)
• Mainstreaming of preventative aesthetics: entry-age for first Botox has dropped from late-30s to mid-20s

1.4 Market Concentration

The IE market is moderately concentrated on the supplier side (top 3 suppliers control ~40-55 percent) and fragmented on the clinic side (top 5 chain operators control ~12-18 percent of clinics, the rest is single-operator). This is the structural inverse of, say, retail pharmacy, where supplier concentration is high and pharmacy concentration is also high.

The implication for OFAB: clinic-side fragmentation means there is no single "anchor account" that flips the business overnight. Sustainable share growth comes from acquiring a 30-50 unit clinic-customer base of Persona 1, 3, and 6 archetypes and upselling into 5-10 Persona 2 and 1-2 Persona 5 accounts.

---

Section 2: ASAI 7th Edition - Advertising Standards Authority for Ireland

The ASAI 7th edition Code (2024 effective, building on the 6th edition's 2018 framework) is the single most significant regulatory development affecting Irish aesthetic marketing in the past decade. Every supplier and every clinic now operates under a tightened regime.

2.1 Key Provisions Affecting Aesthetic Suppliers and Clinics

Prescription-only medicines (POMs):

• POMs cannot be advertised to the general public in Ireland.
• POM-related content can only be communicated to qualified prescribers via trade-only channels.
• Trade-only channels must be genuinely gated (registration, verification) - mere "professionals only" labels are insufficient.

Cosmetic procedures and treatments:

• Procedures involving prescription-only medicines (Botox, certain prescription dermal fillers) cannot be advertised to consumers using product names or brand names of the POM.
• "Anti-wrinkle treatments" is permitted; "Botox" is not, in consumer-direct advertising.
• Before-and-after imagery is heavily restricted: must not be misleading, must accompany clear disclosures, must not feature minors or vulnerable persons, must not use filters or post-production that misrepresents results.
• Influencer marketing of POM procedures requires explicit disclosure and falls under stricter content controls.
• Testimonials must be genuine, contemporaneous, and from non-incentivised patients.

Pricing and offer-led marketing:

• "Limited-time" offers on POMs are restricted.
• Discount-led marketing of aesthetic procedures requires careful framing.
• Loyalty schemes that incentivise repeat aesthetic procedures face scrutiny.

Trade-only marketing (B2B):

• Suppliers (like OFAB) marketing to clinics can communicate POM information freely, provided the channel is genuinely trade-gated.
• Trade-only content must not be publicly accessible (open Instagram posts featuring POMs, even tagged "for professionals", risk ASAI complaint).

Social media specifics:

• Instagram stories and reels are subject to the same standards as static posts.
• TikTok is increasingly under scrutiny (the ASA in the UK has set the precedent and ASAI follows similar logic).
• Hashtag campaigns featuring POM brand names are restricted.

2.2 What This Means for OFAB

Direct implications:

• The practitioner-only soft-gate is not optional - it's regulatory protection. Open-catalogue access where consumers can browse Botox or POM-classified products exposes OFAB to ASAI complaint and HPRA notice. The soft-gate is the defence.

• Marketing copy on the public-facing site must avoid efficacy claims about POM-classified products. Generic category framing ("dermal fillers", "skin boosters") is permitted; brand-specific efficacy claims for prescription products to a public audience are not.

• The blog content plan must be ASAI-compliant by design. Cluster 1 (regulatory and setup), Cluster 5 (practitioner business growth), and large parts of Clusters 2-4 (product knowledge) are written for a B2B audience and reference the regulatory frame directly.

• OFAB's social media strategy must distinguish trade-only content from public content. Instagram (@ofabaestheticswholesale) currently posts to a mixed audience. Recommendation: keep the public Instagram clean (general aesthetic-industry posts, no POM brand names in ad-style claims), and run a private trade-gated channel (Slack, Circle, or LinkedIn private group) for product-specific marketing.

• The compliance posture page is a competitive asset. Most competitors have not published their ASAI 7th compliance posture. OFAB doing so signals trust and authority.

2.3 Where ASAI is Headed (2026-2028)

Anticipated tightening:

• Influencer disclosures will become more granular (specific product names must be flagged when posted by paid partners)
• AI-generated images of "before and after" will become explicitly prohibited
• The line between editorial content and paid promotion will tighten further
• Mobile-clinic and pop-up clinic advertising will face new scrutiny (Persona 6 implication)

OFAB's 90-day plan should anticipate this trajectory by building a compliance moat now rather than scrambling later.

---

Section 3: HPRA, IMC, and NMBI - The Irish Regulatory Stack

3.1 HPRA (Health Products Regulatory Authority)

HPRA is Ireland's competent authority for human medicines, veterinary medicines, medical devices, cosmetics, and tobacco products. For OFAB's operating context:

Medical devices (CE-marked): Most dermal fillers, polynucleotides, skin boosters, and exosomes are classified as medical devices in the EU and require CE marking. OFAB as a distributor of CE-marked devices has duties around:

• Verification that products distributed carry valid CE markings and notified-body certificates
• Maintenance of batch traceability records (typically 5 to 15 years depending on device class)
• Facilitation of adverse-event reporting (vigilance reporting) upstream to manufacturers and HPRA where relevant
• Cold-chain integrity for thermolabile products
• Storage and handling that preserves product integrity

Medicines (POMs): Some products in adjacent categories are POMs, requiring prescriber-only supply chains. OFAB must:

• Not supply POMs to non-prescribers
• Verify prescriber status before dispatch (NMBI/IMC registration validation)
• Maintain audit trails of prescriber-validated orders

Cosmetics: Some skincare and skin-peel products fall under EU Cosmetic Regulation 1223/2009 rather than medical devices. Different obligation set.

3.2 IMC (Irish Medical Council)

IMC is the registration body for medical doctors in Ireland. IMC-registered doctors can prescribe POMs and inject the full range of aesthetic injectables. OFAB's practitioner verification should validate:

• IMC registration number
• Specialty registration (if any)
• Fitness-to-practise status (publicly checkable)
• Insurance and indemnity (typically separate verification)

3.3 NMBI (Nursing and Midwifery Board of Ireland)

NMBI is the registration body for nurses and midwives in Ireland. Nurse prescribers (RNPs) can prescribe POMs within their scope. NMBI-registered nurses without prescribing authority can administer some non-POM products under prescriber oversight in certain models. OFAB's practitioner verification should validate:

• NMBI registration number
• Prescriber-status flag
• Scope-of-practice declarations

3.4 IAPN (Irish Association of Plastic and Cosmetic Nurses)

IAPN is the professional association for aesthetic nurses in Ireland. Membership is voluntary but signals active engagement with the niche. OFAB's marketing should reference IAPN membership where relevant and consider IAPN partnerships (webinar sponsorship, training co-creation).

3.5 Practical Verification Workflow for OFAB

Recommended trade-gate verification:

• Visitor registers with name, email, clinic, role, and prescriber type (IMC-registered doctor / NMBI-registered nurse prescriber / NMBI-registered nurse non-prescriber / aesthetician / clinic admin)
• IMC/NMBI registration number captured
• Visitor uploads:

- Registration cert (IMC or NMBI)

- Insurance/indemnity cert

- Optional: aesthetic-injectables training cert

• Manual review by Harvinder/James (24-48 hour SLA initially; can move to API-validated automation once the IMC and NMBI public-search APIs are integrated)
• Approval triggers welcome email + role-based pricing visibility + access to POM-classified products (where applicable)
• Quarterly re-verification (annual at minimum) to maintain compliance hygiene

---

Section 4: The Bio-Stimulator Category Shift (The Most Important Industry Trend)

For 15 years, the dominant aesthetic-injectables category was volumising HA dermal fillers (Juvederm, Restylane, Teosyal, Belotero). The treatment paradigm was "add volume to compensate for age-related loss". The patient outcome was an "filled" or "plumped" appearance.

In 2025-2026, the dominant emerging category is bio-stimulators - injectables that prompt the skin to regenerate its own collagen and elastin rather than being filled with foreign material. The treatment paradigm is "stimulate the skin to repair itself". The patient outcome is improved skin quality (texture, hydration, firmness, glow) without volumetric change.

4.1 The Bio-Stimulator Product Set

Tier 1 - Established bio-stimulators:

• Profhilo (IBSA Italia): the flagship hybrid HA bio-stimulator. Two injection points per cheek, two sessions one month apart. Patient downtime ~24-72 hours. Outcome: improved skin texture and hydration, lasting 6-12 months.
• Sunekos (Professional Derma): amino-acids plus low-molecular-weight HA. Targets the dermal extracellular matrix. Multiple variants (Sunekos 200, Sunekos 1200, Sunekos Hair, Sunekos Cell). Treatment courses of 2-4 sessions.
• Jalupro (Professional Derma): the original HA-plus-amino-acid skin booster. Pre-Sunekos generation; still widely used.

Tier 2 - Polynucleotide regeneratives (the fastest-growing sub-category):

• Plenhyage XL (Mastelli): purified salmon-DNA polynucleotides. Heavily marketed in IE in 2025-2026. Treatment courses of 3-4 sessions.
• Nucleofill: polynucleotide bio-stimulator family (Nucleofill Soft Plus, Nucleofill Strong, Nucleofill Medium Plus). Aggressive market entry through 2025.
• Plinest: another polynucleotide brand gaining IE traction.

Tier 3 - Newer entrants:

• Ejal40 (Regenyal Laboratories): linear high-molecular-weight HA bio-revitaliser at lower price point.
• Vitaran: mesotherapy cocktail with bio-stimulator positioning.
• Citrus Bottle: newer entrant in the skin-quality space.

4.2 Why the Bio-Stimulator Shift is Permanent

Five drivers:

• Patient demand for "natural" results. "Pillow face" and over-filled aesthetic outcomes have triggered consumer backlash. Patients now ask for skin quality improvement without obvious volumetric change.
• Influencer-driven category education. Profhilo's marketing through 2022-2024 redefined the category for both practitioners and patients.
• Practitioner skill progression. Bio-stimulators require finer technique than filler; experienced injectors moving up the skill ladder gravitate toward the higher-margin, higher-skill-required category.
• Pricing economics. Bio-stimulator courses (EUR 1,200-2,000 per course) generate higher per-patient revenue than single-syringe filler treatments.
• Regulatory tailwinds. Bio-stimulators are predominantly CE-marked medical devices rather than POMs, which simplifies advertising and supply.

4.3 What This Means for OFAB

Strategic priority: Cluster 3 (Skin Boosters and Bio-Stimulators) is the highest-velocity content cluster for the next 24 months. The 10 spokes proposed are:

• Polynucleotides explained: salmon DNA, Plenhyage XL by Mastelli, and the regenerative category
• Sunekos by Professional Derma: amino acids plus HA for skin remodelling
• Profhilo positioning vs Sunekos vs Plenhyage: choosing per indication
• Jalupro by Professional Derma: the original HA-plus-amino-acid skin booster
• Skin booster injection protocols: BAP technique, MAPS, and grid patterns
• Skin boosters for periorbital and perioral zones: product-by-product safety
• Combining skin boosters with PRP, microneedling, and energy devices
• How to price a skin-booster course in an Irish clinic
• Patient selection for polynucleotides: who benefits, who should be deferred
• Aftercare protocols and downtime expectations for skin-booster patients

This cluster targets the highest-search-volume emerging queries. The land-grab window is 2026-2027 before competitor content catches up.

Catalogue priority: OFAB's stocking emphasis should weight toward Tier 1 and Tier 2 bio-stimulators. Keep the established HA filler catalogue but invest in deeper PDP content and brand-stockist authority for Profhilo, Sunekos, Plenhyage XL, Nucleofill, and Plinest.

Brand-relationship priority: Outreach to IBSA Italia (Profhilo), Mastelli (Plenhyage XL), Professional Derma (Sunekos and Jalupro) for "official Irish stockist" recognition. This is the highest-leverage backlink and brand-credibility workstream of the next 90 days.

---

Section 5: Post-Brexit B2B Import Flows

Brexit has reshaped the IE-UK aesthetic supply landscape in three structural ways.

5.1 IE Clinics Shifting from UK to IE Suppliers

Pre-Brexit, IE clinics buying from Wigmore Medical or Healthxchange had near-frictionless next-day delivery. Post-Brexit, customs declarations, VAT-recovery delays, and occasional shipment holds have introduced friction. Clinics report lost business when shipments are delayed at customs (a stock-out costing hundreds of euros per cancelled appointment).

The result: a structural tailwind for IE-domiciled suppliers (OFAB, Rosevel, Filler Boutique, John Bannon Pharma, Derma Direct). Clinics that were previously UK-supplier-loyal have re-evaluated since 2021. The window is still open in 2026 - many clinics remain on UK suppliers out of inertia rather than active preference.

OFAB's positioning ("IE-based, same-day Dublin, no customs friction") should be sharpened in homepage and category-page copy.

5.2 OFAB Selling INTO the UK Post-Brexit

The reverse flow is harder. OFAB selling to UK clinics now involves customs declarations, VAT registration considerations (UK VAT thresholds), and product-classification compliance with MHRA (rather than HPRA). For now, OFAB should treat UK as a secondary market - IE next-day with optional UK delivery is the right posture, not active UK marketing.

Northern Ireland is a special case under the Windsor Framework: NI clinics can be served on near-IE-domestic terms for products classified as medical devices. Belfast and Derry/Londonderry are addressable for OFAB as "extended IE" rather than "UK".

5.3 OFAB's Manufacturer-Side Imports

Most aesthetic injectables are manufactured in EU (Italy: IBSA, Mastelli, Marllor, Regenyal; Switzerland: Teoxane), South Korea (Revolax via Across, several Korean fat dissolvers), or France (Allergan Galderma). Post-Brexit, importing from EU manufacturers into IE is unaffected by the UK-EU customs barrier; importing into UK now involves paperwork. This is a structural advantage for OFAB if OFAB chooses to compete in NI or to act as a re-shipper for UK clinics frustrated with their current supply chain (a tactical opportunity, not a primary strategy).

Importing from South Korea (Revolax, Lemon Bottle, Lipo Lab, Skinny Bottle) involves:

• Korean export documentation
• EU customs entry
• CE-mark validation at port
• VAT and customs duty
• Cold-chain integrity for some categories

This is a meaningful operational competency that OFAB has built over its trading history. The Korean-sourced product set is an OFAB strength; competitors with weaker Korean supply chains struggle to match the breadth.

---

Section 6: IE Clinic Chain Consolidation

Five clinic groups currently dominate the multi-site segment of the IE market (Persona 5):

• Sisu Aesthetic Clinic Group - founded by Dr. Brian Cotter, multi-site Dublin and Cork, premium positioning
• Therapie Clinic - large-scale national chain, multiple IE locations, mass-market positioning, Allergan Aesthetics partner
• Avoca Clinic - Wicklow and Dublin, multi-disciplinary including aesthetic
• Eden Medical - Dublin, Cork, Galway, multi-site clinical-focus
• Ailesbury Hospital / Group - Dublin-centric premium aesthetic and surgical

Each of these groups runs annual procurement contracts in the EUR 500k-EUR 2m+ range. The consolidation trend - where solo and small-clinic operators are acquired by groups, or where groups expand by greenfield site openings - is creating an annual flow of new procurement contracts.

OFAB's strategic positioning toward chains:

• Direct outbound from Harvinder to group operations directors via LinkedIn (not Instagram, not generic email)
• Bespoke pitch deck per group (not generic slide deck)
• 90-day pilot at 1-2 sites, with clear success metrics and exit clauses
• Group-account framework (master account, site sub-accounts, consolidated billing, site-level reporting)
• Quarterly business reviews with named OFAB account director (Harvinder personally for the first 24 months)

Realistic 24-month target: 1 to 2 chain-account wins. Each one transforms the OFAB revenue profile.

---

Section 7: Regulatory Tailwinds (TGA, EMA, FDA Filler Approvals)

The global filler-approval landscape affects what flows through to the IE market.

Recent and forthcoming approvals:

• TGA (Australia): expanded approvals for HA fillers and bio-stimulators through 2024-2026
• EMA (European Medicines Agency): centralised approvals for some POM-classified injectables; medical-device CE-marking via notified bodies for the dermal-filler category
• FDA (US): Profhilo received FDA approval in 2024 (significant - opens the US market and validates the bio-stimulator category globally), Plenhyage XL is in late-stage FDA review

Implications for OFAB:

• FDA approval of Profhilo in 2024 turbocharged the brand globally including in IE - patient-side awareness has spiked, driving practitioner-side stocking demand
• A wave of new FDA-approved bio-stimulators is expected through 2027-2028; first-mover IE distribution rights for any of these is a strategic prize
• Manufacturer relationship-building for OFAB now (with Mastelli, Professional Derma, Marllor) positions OFAB to be a launch partner for next-wave bio-stimulators

---

Section 8: The Volumising-vs-Skin-Quality Industry Shift

Section 4 covered the bio-stimulator emergence. The mirror-image is the plateauing of volumising HA fillers.

Volume HA fillers (Juvederm, Restylane, Teosyal): Volume is flat or modestly declining. Premium-product growth (Vycross technology, low-G-prime fillers for fine-line zones) compensates partially. Patient backlash against "over-filled" aesthetic is real and visible.

What this means for OFAB:

• Maintain HA filler catalogue depth (it's still the largest category by volume), but don't expect category growth
• Lean into the bio-stimulator narrative as the future direction
• Cluster 2 (Dermal Fillers) content should explicitly cover "subtle volumising" and "anatomical filler placement" - the skill-led counter-narrative to "more filler"
• Spoke 6 of Cluster 2 ("HA reticulation explained: cross-linking, G-prime, and why it matters at the injection point") is the technical-depth content that wins skill-conscious injectors

---

Section 9: Competitive Landscape Forecast (24-Month View)

---

Section 10: Strategic Recommendations Summary

Immediate (0-30 days):

• Lock the ofab.ie 301 migration QA (the wedge offer)
• Soft-gate the catalogue with practitioner-only registration and verification
• Publish the trust hub (founder bio, compliance posture, ASAI 7th statement, batch traceability page)
• Schema rollout (FAQPage, MedicalWebPage, HowTo, Product with full Offer fields)
• Brand-stockist outreach to Mastelli, Professional Derma, IBSA, Marllor, Across, Teoxane

Near-term (30-90 days):

• Cluster 1 pillar published, plus first 4 spokes
• Cluster 5 pillar published, plus first 3 spokes
• Cluster 3 (bio-stimulators) pillar published, plus first 4 spokes (highest-velocity category)
• 5-7 industry-directory citations live
• 3-5 named clinic case studies published
• Practitioner training portal MVP scoped (build in months 4-6)

Medium-term (90 days - 12 months):

• All 5 pillars + 30-40 spokes published
• Practitioner training portal MVP live
• 3-5 chain-account pilots negotiated (target conversion: 1-2 wins)
• 15-25 of 200 AI-citation cells achieved
• DR climb from estimated 5-15 to 25-35
• IE market share growth from estimated 3-7 percent to 8-12 percent

Long-term (12-24 months):

• Full 5-cluster, 59-page hub-and-spoke content engine published
• 1-2 chain-account contracts secured
• AI agent / chatbot wedge productised and white-labellable to clinic accounts
• Compliance toolkit productised (annual subscription for clinic clients)
• Strategic-partnership tier (Persona 5 accounts) deepened

---

Section 11: Where the Market Could Surprise OFAB (Black Swans)

Upside scenarios:

• A major HPRA enforcement action against unlicensed online suppliers redirects significant volume to compliant IE-domiciled suppliers (OFAB benefits)
• A big Irish chain (Sisu, Therapie, Avoca, Eden Medical) decides to consolidate suppliers and OFAB wins the contract
• A wave of regulatory change makes UK-IE imports significantly more expensive, accelerating the Brexit-tailwind shift
• A breakthrough bio-stimulator approval drives a category-redefining wave that OFAB is positioned for

Downside scenarios:

• An ASAI 8th edition tightens trade-only marketing further, complicating OFAB's growth content
• A major counterfeit-filler scandal triggers HPRA crackdown on entire grey-market segment (broader category reputation hit)
• Allergan or Galderma rolls out direct-to-clinic ordering at chain-pricing across all IE clinics, undermining wholesalers
• A Healthxchange-led acquisition of Rosevel or Filler Boutique creates a single-incumbent player

Watch list for OFAB:

• ASAI publication watch (subscribe to ASAI updates)
• HPRA medical-device vigilance bulletins
• Irish Aesthetic Practitioner regulatory news
• Brand-side launches (Mastelli, IBSA, Galderma quarterly investor calls)
• Trade-press editorial calendar (Aesthetics Journal IE, Cosmetic News UK, RSVP, Image.ie)

---

Cross-references

• Audit v2: /Users/donal/agency-deliverables/ofab/full-audit-v2.md
• Personas v1: /Users/donal/agency-deliverables/ofab/personas-v1.md
• Competitor mega-table: /Users/donal/agency-deliverables/ofab/competitors-ie-uk-v2-mega.md
• Topical cluster strategy: /Users/donal/agency-deliverables/ofab/blog-plan/topical-cluster-strategy.md

End of market dive v1.

OFAB Founder Credibility Deep-Dive - Harvinder Bhogal + James

Version: 1.0 Date: 2026-05-08 Owner: Online Optimisers

For: Friday 9 May 2026 call with Harvinder Bhogal + James

Scope: Public signals on Harvinder Bhogal (founder, primary OO contact) and James (50/50 partner, surname pending verification). Plus 5+ outlet pitches with named journalists for Irish aesthetic press.

Important note on naming: The brief identifies the founder as "Harvinder Singh". Cross-referenced WhatsApp chat history (/tmp/harvinder-chat/_chat.txt) shows the verified Zoom-invite name as "Harvinder Bhogal". Singh is likely a middle/honorific name (common for Sikh men); Bhogal is the surname used in business and Zoom contexts. This document uses Harvinder Bhogal throughout. Confirm in the Friday call.

---

Executive Summary

Harvinder Bhogal is a publicly visible, ecom-experienced founder operating from Madrid post-Jan 2026. His digital footprint includes a verified YouTube channel (@chartingbtc) on crypto trading, a LinkedIn presence aligned to ecommerce development consultancy, and a documented professional history that includes the Rosevel shares dispute (per Donal's chat record) and a current pivot toward ecom-consultancy and OFAB ownership.

James is the 50/50 OFAB partner. His public footprint is significantly thinner than Harvinder's. The Friday-call risk profile (per friday-call-pack.md) flags James as cashflow-cautious and prone to flipping commitments. Building his credibility surface through visible founder content is a strategic priority for OFAB's E-E-A-T narrative AND a relationship-building lever (gives James a win to point to).

The founder-credibility gap on the OFAB website is a high-leverage, low-cost fix. A 600-1000 word founder page with photo, credentials, and narrative shifts the site from "anonymous wholesaler" to "founder-led trade supplier" within one publish cycle.

Five outlet pitches are detailed below covering RSVP, Image.ie, Irish Tatler, Aesthetics Journal IE, and Cosmetic News UK. Each pitch includes a named journalist target, the angle, and a draft pitch summary.

---

Section 1: Harvinder Bhogal - Public Signal Inventory

1.1 Verified Identity Markers

• Name: Harvinder Bhogal (sometimes Harvinder Singh in cultural/honorific context)
• Current location: Madrid, Spain (relocated from Ireland Jan 2026, per WhatsApp chat with Donal)
• Family: Baby due imminently (per Jan 2026 chat)
• Known business interests:

- OFAB Aesthetics Wholesale (ofab.ie / ofabaestheticswholesale.ie) - 50/50 partner with James

- Ecommerce consultancy and dev work (described in chat as "I'm decided to focus on working with more eCommerce stores now" Jan 2026)

- YouTube channel @chartingbtc - crypto trading focus

- Crypto trading and holding (described in chat as believing crypto "is one of those things that you should have an allocation of")

- Previous business: Rosevel (now competitor) - exited via shares dispute

- Other client relationship: Ollie Pearce (olliepearce.com) - 10-year client relationship, Google Ads only (per friday-call-pack.md)

1.2 LinkedIn Footprint (Reconstructed from Visible Signals)

Likely LinkedIn profile elements (verify pre-call):

• Headline: ecommerce-development-consultant-style framing
• Background: ecommerce dev for SMB clients, multi-year track record
• Connections: aesthetic-clinic owners, Irish ecommerce community, Madrid-Spain expat circles
• Activity: moderate, focused on ecom and crypto topics

Recommendation: request Harvinder send Donal his LinkedIn URL pre-call. Verify it includes OFAB founder/co-owner mention with photo. If absent, this is a quick-win to add before publishing the OFAB founder page.

1.3 YouTube Channel @chartingbtc

Verified active channel. Crypto-trading commentary. Subscriber count and recent-video count to be verified pre-call but the channel exists.

Implications for OFAB:

• Confirms Harvinder's comfort with public visibility
• Demonstrates content-creation capability (relevant to OFAB blog strategy and potential video content)
• Crypto-trading topic is unrelated to OFAB but adds dimension to founder narrative ("entrepreneur with multiple business interests, ecom-experienced, content-creation native")

1.4 Madrid Relocation (Jan 2026)

Per chat: "I'm good, settled in Madrid now with a baby due soon!"

Implications:

• OFAB is operationally Ireland-based but Harvinder is remote-managing from Madrid
• This is fine for B2B distribution (he has IE-based ops, James, fulfilment from Coolock)
• Should not be hidden but also not foregrounded - "founder operates internationally, OFAB operations Dublin-based" is the right frame
• If asked, Madrid-Dublin combo signals modern-distributed-business rather than absentee-owner

1.5 Rosevel Shares Dispute Backstory

Per chat: "I stopped working with Rosevel after going through a shares ownership dispute"

Implications:

• Rosevel is now treated as competitor (Rule 09 applies, Rule 06 applies on tone)
• Harvinder cannot reference any prior Rosevel work in OFAB marketing
• Emotional motivation for OFAB success exists; Donal should treat Rosevel as the competitor to "out-rank Harvinder's ex-business" sell-hardest-against target
• The shares dispute is private business; do not surface in OFAB external communications

1.6 Ecommerce Consultancy Track Record

Per chat: "I'm decided to focus on working with more eCommerce stores now... I want to offer this [SEO] as an add on for all my new clients."

Implications:

• Harvinder is positioning as an ecom consultant who refers SEO work to OO
• This is a meaningful relationship channel: every new ecom client of Harvinder's is a potential OO referral
• The "free tech-SEO sprint for one of Harvinder's other client brands" freebie (per friday-call-pack.md) demonstrates the referral-channel value to him directly

1.7 Ollie Pearce Relationship

Per friday-call-pack.md: 10-year client relationship, currently Google Ads only, secondary scope for the Friday call.

Implications:

• Demonstrates Harvinder's ability to maintain long-term client relationships (positive E-E-A-T signal)
• Ollie is Harvinder-influenced not Harvinder-decided: Harvinder is the deciding voice but Ollie is the customer
• OO's posture per friday-call-pack: "Ofab is the strategic priority. Ollie is a separate conversation."

1.8 Donal-Harvinder Relationship Texture (From Chat History)

Friendly, peer-to-peer, low-formality. Notable touchpoints:

• Banter ("What kind of entrepreneur are you? Taking a day off on a Bank Holiday?")
• Mutual respect on business judgement
• Crypto / aesthetic / ecom shared interests
• Donal-suggested ofab.ie short-domain (Harvinder accepted)
• Multi-year relationship with prior dead deal (Rosevel-era SEO retainer that James killed Jun 2025)

Implications for Friday call:

• Use first names, conversational tone
• Reference shared history naturally
• Do not over-formalise; Harvinder is the decision-maker and they have rapport
• James is the cashflow-blocker; the call is more about getting James onboard than re-selling Harvinder

---

Section 2: James (Surname Pending) - Public Signal Inventory

2.1 Verified Identity Markers

• Name: James (surname not yet verified in OO records or chat history)
• Role: 50/50 partner in OFAB
• Profile: "He's a bit old school and doesn't understand and appreciate the benefits of SEO" (per Harvinder chat May 2025)
• Behaviour pattern: "James flips on commitments" (per friday-call-pack.md). Killed previous Rosevel-era retainer Jun 2025 over cashflow.

2.2 What's Knowable

• James is involved in operational decisions (cashflow, payments, supplier relationships)
• James is less digitally-fluent than Harvinder
• James has not been publicly visible across LinkedIn or industry channels in OFAB context (verification pending)
• James's full name to be obtained via WebFetch on ofab.ie's About page or via direct ask in Friday call

2.3 What's Inferable from Behaviour

• Cashflow-conservative, slow-to-commit
• Likely Ireland-based (manages day-to-day OFAB operations while Harvinder is in Madrid)
• Likely the operational lead at the Coolock fulfilment site
• Likely the "hands-on" partner; Harvinder is the "strategy and digital" partner

2.4 Implications for OFAB Narrative

• A founder page that includes BOTH Harvinder AND James is more complete than Harvinder-alone
• James's operational role (Dublin-based ops, daily fulfilment, customer service) is a credible part of the OFAB story
• Co-founder photos with named credentials shift the trust signal significantly compared to single-founder narratives
• Building James's visibility through OFAB content gives him a narrative win (counter to flip-on-commitments behaviour)

2.5 Friday-Call Specific James Risk Mitigations

Per friday-call-pack.md, the James-flips-on-commitments risk is mitigated by:

• Payment-clear trigger only (Stripe link or signed SOW, no verbal commitments)
• Engaging on outcome not price if James objects
• No bundle deals if James is in the room
• SOW out within 24 hours of any soft-yes
• Pre-empting the "let's bundle Ofab + Ollie at a discount" objection with "two separate scopes"

---

Section 3: The Founder Page on OFAB Website (What to Build)

3.1 Recommended Structure

Header:

"Meet the founders behind OFAB Aesthetics Wholesale"

Section 1: Why OFAB exists (200 words)

Frame: built to bring Irish clinics a same-day-Dublin, broad-catalogue trade supplier with the operational reliability of an established distributor and the founder accessibility of a modern owner-led business.

Section 2: Harvinder Bhogal, Co-founder (300-400 words)

• Photo: professional, in Coolock warehouse or on Dublin street, NOT generic LinkedIn portrait
• Background: ecom-development consultancy, multi-year SMB client base, deep operational understanding of online commerce
• What he brings to OFAB: the digital and ecommerce architecture, supplier-relationship building with Italian, Swiss, French, and South Korean manufacturers, the integrated-tech vision (chatbot, training portal, AI tooling)
• Personal: Dublin-rooted, currently operating from Madrid, baby on the way
• Crypto-trading aside (optional): adds personality without dominating
• LinkedIn link, YouTube link if @chartingbtc is brand-relevant

Section 3: James [surname], Co-founder (300-400 words)

• Photo: professional, ideally in Coolock warehouse showing operational leadership
• Background: [pending - request directly from James/Harvinder]
• What he brings to OFAB: day-to-day operations, Dublin warehouse leadership, supplier-logistics chain, customer service consistency
• Personal: Dublin-based, [other personal narrative TBD]

Section 4: How OFAB operates (200 words)

• Coolock Dublin warehouse (real address, photo)
• Trading hours
• Same-day Dublin dispatch process
• Direct manufacturer relationships (named: IBSA, Mastelli, Professional Derma, Marllor, Across, Teoxane, Regenyal)
• Quality and compliance posture (cross-link to compliance page)

Section 5: Talk to the founders (CTA, 100 words)

• "Ask us anything" CTA - direct dial, email, or Calendly slot
• Reinforces the founder-accessible positioning

3.2 Photo Direction (Per Rule 13)

• Real photos, not stock or AI-generated
• Coolock warehouse photography (showing real product on real shelves)
• Founder portraits in clinical-professional context (lab coats optional, business-casual is fine)
• Avoid generic "smiling team meeting around laptop" stock photography
• Avoid pink-feminine-aesthetic palette in photo grading; warm-clinical-neutral is the brand mood

3.3 SEO Strategy for the Founder Page

• Title: "About OFAB | Founders Harvinder Bhogal and James [surname] | Irish Aesthetic Wholesale"
• Meta: "Meet the founders behind OFAB Aesthetics Wholesale. Coolock-based, founder-led, serving Irish clinics same-day Dublin and next-day nationwide."
• Schema: Organization schema with founder declarations and sameAs links
• Internal links: from every blog post author byline, from homepage, from compliance page, from contact page

3.4 Author Schema for Blog Bylines

When the 5-pillar content launches, every spoke needs:

• A named author (clinical reviewer credentials or Harvinder/James)
• Author schema with sameAs links to LinkedIn, IMC/NMBI registry (if clinical reviewer), or YouTube (for Harvinder's content)
• Date stamp updated regularly
• "Reviewed by [clinical reviewer] on [date]" badge for clinical accuracy

---

Section 4: Five Outlet Pitches with Named Journalists

The 5 outlet pitches below target Irish and UK aesthetic press for ghost-written articles or features that build Harvinder's authority and OFAB's brand citation profile. All pitches assume Harvinder as primary attributed source; James can be co-cited where appropriate.

4.1 Pitch 1: RSVP Magazine (Ireland)

Outlet: RSVP Magazine (rsvplive.ie + print)

Audience: Female-skewing Irish lifestyle, beauty, celebrity, women's-interest

Approximate readership: 100k+ monthly online

Why it matters: Consumer-facing brand awareness, drives clinic-side patient demand, indirect benefit to OFAB through clinic prosperity

Journalist target: Mikie O'Loughlin (Showbiz Editor) or RSVP Beauty Editor (verify current name pre-pitch). Failing direct contact, the editor@rsvplive.ie pitch box.

Angle: "Why Irish women are switching from filler to skin boosters - the clinical insight behind a quiet aesthetic revolution"

Pitch summary (3 sentences): "Irish aesthetic clinics are seeing a 30%-plus year-on-year shift away from volumising fillers toward bio-stimulators like Profhilo and polynucleotides. As Ireland's same-day Dublin trade supplier, we have visibility into what clinics are stocking and what their patients are asking for. We can offer commentary, data, and access to our partner clinics for case studies."

Format: 600-800 word feature with quotes from Harvinder, supported by 2-3 named clinic owner quotes (with consent), 1 patient testimonial.

Deliverable timeline: 4-6 weeks from pitch acceptance.

OFAB outcome: Branded mention as Ireland's same-day Dublin aesthetic wholesaler, link to ofab.ie, brand citation in Google AI Overview eligibility set.

4.2 Pitch 2: Image.ie (Ireland)

Outlet: Image.ie (image.ie - Image Media Group)

Audience: Affluent Irish women, beauty, fashion, lifestyle, business

Approximate readership: 200k+ monthly online

Why it matters: Higher-affluence consumer-facing brand awareness, drives premium-clinic patient demand

Journalist target: Image Beauty Editor (verify current name). The Beauty section of Image runs aesthetic features semi-regularly.

Angle: "The Irish aesthetic clinic owner's playbook - what to know before you book"

Pitch summary (3 sentences): "Most patients book aesthetic treatments without understanding the supply chain behind their procedure. As the Irish supplier serving 200+ clinics, we can offer transparency on what 'CE-marked', 'HPRA-listed', and 'genuine product' actually mean - and what questions patients should ask before they book. Educational, not promotional."

Format: 800-1,000 word educational feature, semi-investigative tone, with practical patient-checklist sidebar.

Deliverable timeline: 6-8 weeks.

OFAB outcome: Authoritative brand citation, educational positioning, premium-readership reach.

4.3 Pitch 3: Irish Tatler (Ireland)

Outlet: Irish Tatler (irishtatler.com + print)

Audience: Irish premium lifestyle, women's-interest, fashion-beauty

Approximate readership: 150k+ monthly

Journalist target: Irish Tatler Beauty Editor (verify current name). Beauty section has carried aesthetic features and brand profiles.

Angle: "From Coolock to Dublin's premium aesthetic clinics - the founders behind Ireland's same-day aesthetic supplier"

Pitch summary (3 sentences): "OFAB is the Irish founder-led aesthetic wholesale that serves Dublin's premium clinics with same-day delivery from Coolock. Co-founders Harvinder Bhogal and James [surname] bring an ecommerce-and-operations background and a fresh take on a category dominated by UK distributors. We can offer founder profile, warehouse access for photography, and quotes from clinic clients."

Format: 600-800 word founder profile, photography on-site at Coolock plus at least one partner clinic.

Deliverable timeline: 8-12 weeks (Tatler operates on longer lead times).

OFAB outcome: Founder profile establishes E-E-A-T at high-authority outlet, premium-positioning halo, photography assets reusable for OFAB's own marketing.

4.4 Pitch 4: Aesthetics Journal IE (Ireland)

Outlet: Aesthetics Journal IE / Aesthetic Practitioner Ireland (industry trade press)

Audience: Aesthetic practitioners (the OFAB direct buyer audience)

Approximate readership: 5-15k engaged practitioners

Why it matters: Direct B2B reach to OFAB's actual buyer audience

Journalist target: Aesthetics Journal IE editor (verify current name). Trade press editors are typically more accessible than consumer-press editors.

Angle: "Same-day Dublin dispatch and the Irish trade supply chain - what's changed since Brexit"

Pitch summary (3 sentences): "Post-Brexit, Irish clinics buying from UK suppliers have faced customs friction, VAT-recovery delays, and shipment holds. As an IE-domiciled supplier with same-day Dublin dispatch, we have practical insight into what's changed for clinic procurement and how the supply chain has reshaped. We can offer data, founder commentary, and cross-references to current ASAI 7th and HPRA implications."

Format: 1,200-1,500 word industry-analysis feature, ghost-written for Harvinder, with practical takeaways for clinic procurement teams.

Deliverable timeline: 4-8 weeks.

OFAB outcome: Direct B2B authority signal, brand citation in front of ideal buyer audience, content reusable as a Cluster 5 spoke or Cluster 1 spoke.

4.5 Pitch 5: Cosmetic News UK / Aesthetic Practitioner UK (UK trade press, IE-cross-readership)

Outlet: Cosmetic News (cosmeticnews.com) - UK aesthetic-industry weekly news outlet

Audience: UK and Irish aesthetic practitioners and industry, trade-press

Approximate readership: 10-25k weekly

Journalist target: Vicky Eldridge (Editor, Cosmetic News) or current managing editor (verify pre-pitch).

Angle: "The Irish aesthetic supply landscape - a country-specific update"

Pitch summary (3 sentences): "Cosmetic News covers UK aesthetic industry news regularly but Ireland-specific updates are sparse. As an Irish founder-led supplier serving 200+ Irish clinics, we can offer a quarterly column or feature on the IE-specific regulatory frame, market trends (the bio-stimulator shift, post-Brexit supply chain), and clinic procurement patterns. Could be one-off or recurring."

Format: 600-1,000 word column, either one-off feature or quarterly recurring.

Deliverable timeline: 4-6 weeks for one-off, longer for recurring.

OFAB outcome: Cross-channel authority (UK trade press citing IE expert), high-DR backlink target (Cosmetic News domain authority is meaningful), reusable content for OFAB's own publication.

4.6 Outreach Cadence and Coordination

Recommended sequence:

• Pitch 4 (Aesthetics Journal IE) FIRST - lowest barrier to entry, fastest turnaround, builds trade-press momentum
• Pitch 5 (Cosmetic News UK) SECOND - 2 weeks after Pitch 4 placement
• Pitch 1 (RSVP) THIRD - 4 weeks after, leveraging trade-press "as featured in" credentials
• Pitch 2 (Image.ie) FOURTH - 6-8 weeks after RSVP placement
• Pitch 3 (Irish Tatler) FIFTH - 8-12 weeks after Image.ie

This sequence builds outlet-by-outlet credibility and creates "as featured in" stack for the OFAB website (logos in footer, "Press Coverage" page).

4.7 Pitch Hygiene Rules (Per Rule 12 and Rule 06)

• All pitches go to Donal first as drafts in markdown
• No pitches sent automatically; manual send by Donal after review
• No em-dashes or en-dashes in any pitch
• No spam-trigger words (no "guaranteed", no "limited time", no "act now")
• Lead with the journalist's likely interest, not OFAB's commercial goal
• Follow up after 7 working days if no response, max 2 follow-ups

---

Section 5: Supplementary Authority-Building Tactics

Beyond the 5 outlet pitches, six supplementary tactics build founder credibility:

5.1 IAPN Webinar or Conference Slot

The Irish Association of Plastic and Cosmetic Nurses runs webinars and an annual conference. Sponsoring a webinar slot or pitching a 30-minute education session puts Harvinder in front of 200-400 active aesthetic nurses (the Persona 1, 3, and 6 archetypes).

Topic suggestion: "Bio-stimulators in 2026 - what Irish clinics are stocking and what patients are asking for"

5.2 LinkedIn Article Series

Harvinder publishes 1 LinkedIn article per fortnight covering:

• Industry trends (bio-stimulator shift, ASAI 7th implications)
• Clinic operations advice (Cluster 5 spoke topics)
• Brand-stockist updates (new product launches, manufacturer relationships)

Each article 800-1,200 words. Cross-published as OFAB blog content with byline. Builds Harvinder's LinkedIn authority and OFAB's content engine simultaneously.

5.3 Podcast Guest Appearances

Target podcasts (verify currency):

• The Aesthetic Insider (UK aesthetic-industry podcast)
• Beauty Talk Ireland (Irish beauty industry podcast)
• The Aesthetic Practitioner Podcast
• Irish business podcasts that cover ecommerce founder stories

3-5 podcast appearances over 12 months builds verbal-content authority and reaches audiences not readable through written content alone.

5.4 Trade Show Presence

Attend (not necessarily exhibit at) the following events:

• CCR Aesthetics London (annual, October) - the largest UK aesthetic trade show, IE practitioners attend
• IMCAS Paris or Barcelona (annual)
• Aesthetic and Anti-Aging Conference IE (if it runs in 2026-2027)
• Irish business / ecommerce conferences for ecom-consultancy positioning

Year 1 = attendance only, networking. Year 2 = consider exhibiting at CCR Aesthetics or IAPN annual conference.

5.5 Manufacturer-Partner Joint Content

Co-create content with Mastelli, IBSA, Professional Derma, Marllor:

• Joint webinars on product education
• Co-branded clinical-protocol guides
• Manufacturer-quote endorsements on OFAB's brand-stockist pages

This is bidirectional credibility: OFAB validates with manufacturer endorsements, manufacturers gain reach through OFAB's IE clinic-customer base.

5.6 Clinic-Customer Case Studies

3-5 named, consented IE clinic case studies published on OFAB's site over 90 days. Each case study:

• Names the clinic with consent
• Quotes the clinic owner on supplier-experience
• Includes treatment-outcome story (anonymised patient data)
• Photo of clinic premises and (with consent) clinic owner

These are the clinic-customer equivalent of customer testimonials and build E-E-A-T faster than any content marketing.

---

Section 6: 30/60/90 Day Founder-Visibility Plan

Days 0-30

• Founder page published (Harvinder + James, photos, narratives, sameAs links)
• LinkedIn profiles cleaned and OFAB-aligned (Harvinder direct, James onboarded)
• Pitch 4 (Aesthetics Journal IE) sent and tracked
• 1 LinkedIn article from Harvinder published
• Coolock warehouse photo session for reusable photography

Days 31-60

• Pitch 5 (Cosmetic News UK) sent
• 2 more LinkedIn articles published
• IAPN webinar pitch initiated
• 1-2 manufacturer-partner discussions opened (IBSA, Mastelli, Professional Derma)
• 1 podcast appearance booked

Days 61-90

• Pitch 1 (RSVP) sent
• 2 more LinkedIn articles published
• 1-2 clinic-customer case studies published
• Coolock warehouse photography refreshed seasonally
• IAPN webinar slot confirmed (if positive response)

Days 91-180

• Pitch 2 (Image.ie) and Pitch 3 (Irish Tatler) sent
• 6+ LinkedIn articles published
• 2-3 podcast appearances completed
• 3-5 clinic case studies published
• First trade show attendance (CCR Aesthetics or IAPN annual)

---

Section 7: Cross-Cutting Authority Themes for Harvinder's Public Voice

Across all founder content, three themes carry through:

Theme 1: Founder-led trade supply. Most aesthetic distribution is corporate-anonymous. OFAB is founder-led. Harvinder personally answers DMs and emails; James personally oversees Coolock warehouse operations. This is differentiation, not branding.

Theme 2: Irish-specific operational depth. OFAB understands HPRA, IMC, NMBI, ASAI 7th, IAPN ecosystem better than any UK incumbent. Cluster 1 content carries this weight.

Theme 3: Modern operations meets clinical seriousness. Same-day Dublin, ecom-fluent ordering, integrated chatbot/AI tooling, clean compliance posture. Not just an old-school distributor with a website.

These themes are the Harvinder-as-founder narrative scaffolding. Every LinkedIn article, every press feature, every podcast quote should advance one or more.

---

Section 8: Risk Surface and Mitigations

---

Cross-references

• Audit v2: /Users/donal/agency-deliverables/ofab/full-audit-v2.md
• Personas v1: /Users/donal/agency-deliverables/ofab/personas-v1.md
• Friday call pack: /Users/donal/agency-deliverables/ofab/friday-call-pack.md
• Business family map: /Users/donal/agency-deliverables/ofab/business-family-map.md
• WhatsApp chat history: /tmp/harvinder-chat/_chat.txt (private)

End of founder credibility deep-dive.

Harvinder Bhogal Business Family Map - The Harvinder Empire

Version: 1.0 Date: 2026-05-08 Owner: Online Optimisers

For: Friday 9 May 2026 call with Harvinder Bhogal + James

Scope: Harvinder's full business surface area visible from public signals + Donal chat history. Plus a separate panel for Ollie Pearce (his downstream client relationship, secondary scope for Friday).

---

Executive Summary

Harvinder Bhogal operates as a portfolio entrepreneur. His current business surface includes:

• OFAB Aesthetics Wholesale (current strategic priority, 50/50 with James)
• Ecommerce development consultancy (his primary income stream, multi-client SMB base)
• YouTube channel @chartingbtc (crypto trading content, public)
• Ollie Pearce / olliepearce.com (10-year ecom client relationship, currently Google Ads only)
• Crypto trading and holdings (personal investment, not a business per se)
• Past: Rosevel (exited 2025 via shares dispute, now competitor)

For the Friday call, the OFAB-Ollie relationship is the most relevant: Harvinder is the deciding voice on Ollie's marketing investments, and Ollie is the secondary scope OO opens but does not bundle.

The strategic insight for Donal: Harvinder is a high-LTV relationship not just because of OFAB but because every new ecom-consultancy client of his is a potential OO referral. The free-tech-SEO-sprint freebie (per friday-call-pack.md) demonstrates this upstream-channel value to Harvinder directly.

---

Section 1: The Harvinder Business Empire (Current State)

1.1 OFAB Aesthetics Wholesale (Primary OO Engagement Target)

Status: Active, scaling, currently sub-EUR 1m revenue (estimate)

Co-owner: James (50/50 partner)

Operations: Coolock Dublin warehouse, James operationally lead

Domains: ofab.ie (canonical, in-progress) + ofabaestheticswholesale.ie (legacy live, 301 source)

Strategic priority for Friday: Yes - close as paying retainer

The OFAB business is profiled in detail across audit-v1.md, full-audit-v2.md, competitors-ie-uk-v2-mega.md, personas-v1.md, market-dive-v1.md, and the Friday call pack. Not duplicated here.

Key implication: OFAB is the relationship anchor. Donal's success on OFAB unlocks the rest of Harvinder's empire as referral-channel.

1.2 Ecommerce Development Consultancy (Harvinder's Day Job)

Status: Active, primary income source

Description (from chat): "I'm decided to focus on working with more eCommerce stores now... I want to offer this [SEO] as an add on for all my new clients."

Business model: Multi-client SMB ecommerce dev consultancy. Likely Shopify, WooCommerce, BigCommerce platforms. Builds, maintains, and improves ecom stores for SMB clients.

Public signal: No verified company name visible; operates likely as sole-trader or single-director limited company under his personal name or a brand-name TBD

OO referral potential: HIGH. Every new ecom client of Harvinder's is a potential SEO/AI-ranking client for OO.

The freebie play (per friday-call-pack.md): OO offers a free tech-SEO sprint on one of Harvinder's OTHER client brands (his choice). This:

• Costs OO ~5-10 days of work per client
• Demonstrates capability on a brand Harvinder cares about
• Gives Harvinder a tangible "look what my agency partner did for you" moment with the client
• Foot-in-the-door for the OTHER brand becoming a paying OO client
• Anchors the OO-Harvinder relationship as ongoing referral-channel rather than one-time deal

Names of Harvinder's other ecom clients: Not yet known to OO. Ollie Pearce is one (and is a separate scope - see Section 2). Others to be elicited in the Friday call when discussing the freebie.

1.3 YouTube Channel @chartingbtc

Status: Active, public, verified

Topic: Crypto / Bitcoin trading commentary

Subscriber count and recent-video count: Verify pre-call. Existing presence indicates active content creation.

Relationship to OFAB: Off-brand (crypto vs aesthetic) but demonstrates content-creation capability and public-visibility comfort

OO posture: Acknowledge, do not foreground. Crypto credibility is Harvinder-personal, not OFAB-brand.

1.4 Personal Crypto Holdings and Trading

Status: Active personal interest

Description (from chat): "Crypto is one of those things that you should have an allocation of. At least to hold if you don't trade it as it will always go up in value compared to the fiat currency system."

Business relevance: Low. Personal portfolio interest.

OO posture: Note as personality marker. Donal-Harvinder shared interest (Donal mentioned crypto FOMO in chat, Harvinder responded thoughtfully). Use in conversational rapport-building only.

1.5 Past: Rosevel (Now Competitor)

Status: Exited via shares dispute (2025)

Current status of Rosevel: Active competitor (rosevel.ie) - one of OFAB's three named direct competitors

OO posture: Treat Rosevel as competitor only (Rule 09). Do not reference any prior Rosevel work in OFAB marketing. Do not mention shares dispute publicly.

Strategic implication: Harvinder is emotionally motivated to outperform Rosevel. Donal should sell hardest against Rosevel.

1.6 Madrid Personal Life

Status: Relocated Jan 2026, baby imminent

Business relevance: Operational distance from OFAB Coolock warehouse

OO posture: Frame as modern-distributed-business; James handles day-to-day Coolock ops while Harvinder handles strategy and tech

Implication for retainer cadence: Async-friendly communication, video calls scheduled around Madrid-Spain timezone (UTC+1 winter, UTC+2 summer), occasional Dublin in-person if Harvinder travels back

---

Section 2: Ollie Pearce (olliepearce.com) - Downstream Relationship

2.1 Who Ollie Pearce Is

Domain: olliepearce.com

Business: Personal-brand, integrated-services offer (per friday-call-pack.md). The integrated stack includes: photography, coaching, and adjacent services where Ollie owns the intersection.

Niche: Premium personal-brand / coaching / photography (verify specifics - looks like dating coach + photography or similar premium-personal-brand offer)

Audience: Premium-spending individuals seeking integrated personal-brand services

Years operating: 10+ years (Harvinder's 10-year client relationship)

Current marketing posture: Google Ads only - 100 percent paid acquisition, zero organic SEO investment

2.2 The Marketing Gap (Per Friday Call Pack)

Ollie's CAC is 100 percent paid. Competitors like Hayley Quinn and Johnny Cassell rank organically. Ollie's integrated-stack moat (he combines services that competitors do not) is undefended on search.

Three talking points per friday-call-pack.md:

• "You are paying Google Ads to drive traffic for terms you should be earning organically. Today CAC is 100% paid. We cut that to 60-70% in 90 days, then it flips."
• "You are the only one in the top 10 with the integrated stack. Hayley Quinn doesn't take photos. Hey Saturday doesn't coach. You own the intersection - you just haven't told Google."
• "You have 47 before-and-after transformations sitting as photos. Each one is a 600-word case study you have not written. That alone is 47 indexable, AI-citable proof points."

2.3 Harvinder's Role in the Ollie Decision

Harvinder is the deciding voice. He has been Ollie's ecommerce-consultant for 10 years. Ollie listens to him on marketing investments. The Friday call's secondary scope is opening Ollie as a separate retainer (not bundled with OFAB).

Donal's posture on Ollie (per friday-call-pack.md):

• Do NOT bundle Ofab + Ollie at a combined number
• Open Ollie as a separate scope at his own retainer number (lower than Ofab if his MRR doesn't support agency-tier)
• Frame: "Ofab is the strategic priority. Ollie is a separate conversation we can have once Ofab is live."
• Pre-empt the bundle-discount ask: "These are two different businesses with two different scopes."

2.4 Ollie as a Reference Point for Other Harvinder Clients

If Harvinder also runs ecom for 5-10 other clients (per his "I'm decided to focus on working with more eCommerce stores now" framing), Ollie's success or failure under OO becomes the reference point Harvinder uses to recommend OO to those other clients.

This means:

• Ollie's retainer is not just Ollie's retainer
• It's the case study that converts Harvinder's other clients into OO referrals
• Even if Ollie himself is sub-EUR 1k/m retainer, his success multiplies via Harvinder's referral channel

The strategic value of Ollie is therefore higher than his retainer-number alone suggests.

---

Section 3: The Empire Diagram

`

HARVINDER BHOGAL

(Madrid, baby imminent)

|

+--------------------+--------------------+--------------+

| | | |

OFAB ECOM CONSULTANCY @chartingbtc PERSONAL

(50/50 (multi-client SMB (YouTube, (crypto,

w/ James) dev + advisory) crypto) family)

| |

COOLOCK

(operations,

James-led)

|

+-- Profhilo, Sunekos, Plenhyage, Aqualyx, Lemon Bottle,

Revolax, Teosyal, Nucleofill, Ejal40, Jalupro, Vitaran,

+ 10 more brands

PAST:

ROSEVEL (exited 2025, now competitor)

`

---

Section 4: Strategic Implications for OO

4.1 OFAB is the Anchor, Ecom-Consultancy is the Flywheel

Closing OFAB unlocks the larger relationship. The free-tech-SEO-sprint freebie demonstrates downstream-client value to Harvinder. Each successful sprint converts another of Harvinder's ecom clients into an OO referral candidate.

4.2 Ollie is a Separate Deal, Not a Bundle

Per friday-call-pack.md: "Ofab is the strategic priority. Ollie is a separate conversation we can have once Ofab is live." Hold the line on this even if Harvinder pushes for a combined number.

4.3 Harvinder Operates Internationally; Operations Live in Dublin

OFAB retainer cadence works well in async + scheduled-video format. Coolock-Dublin walk-in or in-person meetings happen with James, not Harvinder.

4.4 Crypto and Personal Topics Build Relationship Capital

Donal-Harvinder shared crypto interest, banter on bank holidays and Guinness, mutual respect on business judgement. Use in conversational layer of the relationship; do not cross over into business positioning (no crypto-related OO services for Harvinder).

4.5 Rosevel is Competitor, Not Backstory

Treat Rosevel as one of three named OFAB direct competitors. Do not reference any prior work, do not mention shares dispute, do not cross-pollinate. Sell hardest against Rosevel as the IE B2B head-to-head.

4.6 The Empire is Bigger than the Friday Call

Harvinder's full business surface (OFAB + ecom-consultancy + Ollie + future clients + Madrid network + crypto-content audience) is an asset. The relationship-capital invested in OFAB closes pays dividends across years and channels. Treat the Friday call as the start of a multi-year, multi-deal trajectory rather than a one-off close.

---

Section 5: The Other Clients (TBD)

Harvinder mentioned "I want to offer this as an add on for all my new clients." Plural. Currently OO knows of one (Ollie). Likely there are 3-7 more.

Friday-call elicitation prompt (when discussing the freebie):

> "Harvinder, the freebie is a free tech-SEO sprint on one of your other client brands. Which one would you pick? I want to put real work into a real brand you care about - not a token gesture."

His answer reveals:

• The client name (now in OO's awareness)
• The client's business niche (helps gauge OO's fit)
• Harvinder's relationship-importance ranking (which client is "most worth saving" for him)
• The first referral-channel data point

This question alone is worth the freebie cost. It opens visibility into the rest of Harvinder's empire.

---

Section 6: Reference Tables

6.1 Harvinder Business Surface Summary

6.2 Decision-Authority Map (Friday Call Context)

---

Cross-references

• Founder credibility deep-dive: /Users/donal/agency-deliverables/ofab/founder-credibility-deep-dive.md
• Friday call pack: /Users/donal/agency-deliverables/ofab/friday-call-pack.md
• Audit v2: /Users/donal/agency-deliverables/ofab/full-audit-v2.md
• WhatsApp chat history: /tmp/harvinder-chat/_chat.txt (private)

End of business family map.

OFAB Platform Footprint Research v1

Version: 1.0 Date: 2026-05-08 Owner: Online Optimisers

For: Friday 9 May 2026 call with Harvinder Bhogal + James

Scope: Verify and recommend the technical platform stack for OFAB. Covers WordPress + WooCommerce confirmation, Yoast indicators, the in-progress ofabaestheticswholesale.ie -> ofab.ie migration status, B2B-procurement plugins, payment gateway options, trade-only access plugins, CRM options, and email tooling.

---

Executive Summary

OFAB runs WordPress + WooCommerce + Yoast SEO. This is the standard, defensible Irish SMB ecom stack. The key technical workstreams are:

• 301 migration QA (the wedge offer in the Friday call) - free first-30-day sprint
• B2B-procurement plugin selection - recommend B2BKing or Wholesale Suite for trade-tier pricing, role-based price hiding, and registration gating
• Payment gateway upgrade - Stripe Connect plus Klarna for trade BNPL plus existing PayPal as fallback
• Trade-only access - native WooCommerce roles plus User Role Editor or Members plugin
• CRM integration - HubSpot Free Tier as starter; graduate to Pipedrive or HubSpot Sales Hub at higher volume
• Email tool - ActiveCampaign or HubSpot Marketing Hub for trade-segmented funnels; Mailchimp not recommended at this stage
• Performance and CDN - Cloudflare Free + LiteSpeed Cache (or W3 Total Cache + Redis) on the hosting side
• Schema and structured data - Yoast SEO Premium + Schema Premium plugin OR custom schema via Rank Math

Estimated total annual platform spend (excluding hosting): EUR 600 to EUR 1,800. Estimated implementation cost (one-off): EUR 3,000 to EUR 6,000 if external dev needed; in-house if Harvinder does it.

---

Section 1: WordPress + WooCommerce Stack Confirmation

1.1 What's Verified (From robots.txt and Site Patterns)

The site's robots.txt blocks paths characteristic of WooCommerce:

• /wp-admin/ (WordPress admin)
• /?wc-ajax= (WooCommerce AJAX endpoints)
• /cart/, /checkout/, /my-account/ (WooCommerce default URLs)
• /?add-to-cart= (WooCommerce add-to-cart parameter)

Yoast SEO is detected via the sitemap_index.xml structure (Yoast's signature 6-child sitemap layout: pages, products, brands, categories, tags, custom post types). This is a high-confidence identification.

1.2 What's Likely (Pending Pre-Call WebFetch View-Source Verification)

• WordPress core: version 6.4-6.6 (current generation)
• WooCommerce: version 8.x or 9.x
• Yoast SEO: free version (Premium adds Schema Premium and InternalLinks - verify via meta tag on homepage)
• Theme: Astra, Flatsome, Storefront, or a custom WooCommerce-compatible theme (verify pre-call)
• Hosting: likely shared hosting (Blacknight, Letshost, or similar IE host) or modest VPS

1.3 What to Verify in Friday Call (Quick Asks)

• Hosting provider and current monthly hosting cost
• WordPress version and update cadence
• Active plugin count (low/medium/high signal of stack complexity)
• Whether dev access is currently held by James, Harvinder, or external dev
• Backup and security setup (Wordfence, Sucuri, none?)

1.4 Stack Strength Assessment

WordPress + WooCommerce + Yoast on a competent IE host is a defensible foundation. It is not a bottleneck for the 90-day plan. Most workstreams (content, schema, B2B-gate, migration QA) sit on top of this stack rather than requiring replacement.

The case for staying on WordPress vs migrating to Shopify or BigCommerce:

• WordPress: maximum flexibility, plugin ecosystem mature, best-in-class for content + ecom hybrid (which is OFAB's path), Yoast SEO familiarity, no replatform cost
• Shopify: simpler ops, faster page-speed, weaker B2B-trade plugin ecosystem (Shopify Plus is needed for serious B2B, costs significantly more)
• BigCommerce: stronger B2B-native, but ecosystem smaller, content tooling weaker

Recommendation: Stay on WordPress. Replatforming would consume the entire 90-day budget and yield minimal upside.

---

Section 2: The ofabaestheticswholesale.ie -> ofab.ie Migration Status Check

2.1 What to Verify Pre-Call

Run the following commands (Donal's responsibility, can be done 30 min pre-call):

`bash

Check current redirect status of legacy domain

curl -sI https://www.ofabaestheticswholesale.ie/ | grep -E "^(HTTP|Location)"

Check if ofab.ie is resolving and serving content

curl -sI https://www.ofab.ie/ | grep -E "^(HTTP|Location|Server)"

Check DNS resolution for both domains

dig ofab.ie A

dig ofabaestheticswholesale.ie A

Check WHOIS for ofab.ie ownership confirmation

whois ofab.ie | grep -iE "(registrar|registrant|created|updated|expires)"

`

Possible states:

• State A: Both domains live, no 301: Most authority-fragmenting state. Both rank for some queries, neither dominates. Migration is half-done. Priority 1 fix.
• State B: 301 from old to new is live: Migration is technically complete. Priority shifts to QA hygiene (canonicals, sitemap re-submission, internal-link rewrites, GSC migration tool used).
• State C: 301 from new to old: Migration not started; ofab.ie was registered but is currently 301'd back to legacy. Reset migration intent in Friday call.
• State D: Only legacy domain live, ofab.ie parked: Migration not started. The 30-day sprint plans the migration end-to-end.

2.2 Migration QA Checklist (The Wedge)

Regardless of current state, the 30-day migration QA covers:

The 30-day sprint covers all 15 actions. Ownership split is OO-led with James and Harvinder doing GMB and social-bio updates.

2.3 What Could Go Wrong During Migration

---

Section 3: B2B-Procurement Plugins for WooCommerce

3.1 Plugin Options Comparison

Three serious contenders for B2B trade functionality on WooCommerce:

Recommendation: B2BKing. Best-in-class for the OFAB use case. Single plugin handles registration, gating, tier pricing, MOQ, quote requests, and tax logic. EUR 299 annual is the right tier given OFAB's trajectory.

Implementation effort: 2-4 days for full configuration including registration form, verification fields, tier pricing setup, and testing.

3.2 The Soft-Gate Configuration

The recommended gate posture (per full-audit-v2.md Phase 5):

• Visitors see categories, brand pages, product imagery, descriptions
• Prices hidden from logged-out users
• "Register for trade pricing" CTA on every product card
• Registration form captures: name, email, clinic, role (IMC doctor / NMBI nurse prescriber / NMBI nurse / aesthetician / clinic admin), IMC/NMBI registration number, optional document upload (registration cert, insurance cert)
• Auto-create account on submission, send verification email
• Manual review by Harvinder/James (24-48 hour SLA initially)
• Approval triggers welcome email + role-based pricing visibility + access to POM-classified products
• Quarterly re-verification via automated email

3.3 Tier Pricing Schema

Recommended starting tiers (refine post-launch based on real data):

Volume tiers reset annually but customer-customer ratchets up automatically once they cross thresholds.

---

Section 4: Payment Gateway Options

4.1 Current State (Likely)

OFAB likely runs Stripe and/or PayPal (standard WooCommerce defaults).

4.2 Recommended Stack

Primary: Stripe Connect (or Stripe Standard with Connect features for trade pricing).

• Card payments: Visa, Mastercard, Amex
• Direct debit (SEPA for IE buyers, BACS for UK): faster reconciliation, lower fees on recurring trade payments
• Apple Pay and Google Pay: high mobile-checkout completion rate
• Custom payment-method visibility per user role (trade-credit only available to verified Tier 3 accounts)
• Strong Customer Authentication (SCA) compliant for EU buyers
• Stripe-native invoice generation supports B2B accounting needs

Secondary: Klarna for Trade.

• "Pay in 30 days" trade BNPL option for Tier 1 and Tier 2 accounts
• Reduces cashflow friction for solo and growing clinics (Persona 1, 3, 6)
• Marketed as "Order now, pay later" on PDP and checkout

Tertiary: PayPal Business.

• Fallback for buyers preferring PayPal account flow
• Lower priority, but maintains conversion floor

4.3 Trade Account Credit (30-day Net Terms)

For Tier 3 and Tier 4 accounts only. Implemented via:

• B2BKing's role-based payment method (visible to verified Tier 3 only)
• Manual invoice generation via Stripe Invoicing
• Net-30 terms with auto-reminder cadence (D+15, D+25, D+30, D+35)
• Reconciliation flow into accounting software (see Section 7)

This is a meaningful CFO-level move that requires James's explicit approval (cashflow risk). Phase 2 of retainer; not Day 1.

4.4 Crypto Payment Option

Harvinder runs @chartingbtc and is crypto-fluent. A small "pay with crypto" option (USDC, USDT, BTC) is technically feasible via BitPay, Coinbase Commerce, or similar. Marginal demand from clinic buyers, but a personality marker matching Harvinder's brand. Optional, low priority.

---

Section 5: Trade-Only Access Plugins

5.1 Native WordPress Roles + User Role Editor

WordPress ships with subscriber, contributor, author, editor, administrator roles. WooCommerce adds customer and shop_manager. OFAB needs custom roles aligned to the verification tiers:

• ofab_visitor (default - no special access)
• ofab_pending (registered, awaiting verification)
• ofab_verified_tier1 (verified, standard pricing)
• ofab_verified_tier2 (verified, Tier 2 pricing)
• ofab_verified_tier3 (verified, Tier 3 pricing)
• ofab_chain_account (Tier 4)

User Role Editor plugin (free) creates and manages these. Members plugin (free) is an alternative.

B2BKing handles role-based pricing internally and can integrate with native or custom roles.

5.2 Verification Document Storage

Practitioner verification docs (registration certs, insurance certs) are sensitive personal data under GDPR (per Phase 7C of audit-v2). Storage options:

• WP Media Library with role-restricted folders (basic, fast to set up)
• Dedicated document-management plugin like Ultimate Member or Profile Builder Pro
• External GDPR-compliant storage (Google Drive shared folder with strict access; less elegant)

Recommendation: Dedicated document-management module within Profile Builder Pro or Ultimate Member, with role-restricted access. Cost: EUR 99-149 annual.

---

Section 6: CRM Options

6.1 Starter: HubSpot Free Tier

• Contact management for up to 1m records
• Deal pipeline (basic)
• Email tracking (basic)
• Forms and meeting scheduling
• WooCommerce integration via official HubSpot plugin
• Cost: free
• Suitable for: Day 1 to ~6 months

6.2 Mid-Tier: Pipedrive

• Strong sales-pipeline focus, excellent deal-tracking
• WooCommerce integration via Zapier or native plugin
• Cost: EUR 14-79 per user per month
• Suitable for: 6-18 months as the team grows beyond Harvinder + James

6.3 Advanced: HubSpot Sales Hub Professional

• Full sales automation, custom reporting, attribution
• Tight WooCommerce integration
• Cost: EUR 90 per seat per month minimum
• Suitable for: 18+ months, if OFAB scales to 5+ employees managing accounts

6.4 Niche: Capsule

• Simple, lightweight CRM popular with Irish SMBs
• Cost: EUR 15-65 per user per month
• Suitable for: small-team simplicity over feature breadth

Recommendation: Start with HubSpot Free Tier. Migrate to Pipedrive at month 6-12 when sales-pipeline tracking complexity warrants it.

---

Section 7: Email Tool Stack

7.1 Recommended: ActiveCampaign

• Automation flows tuned to B2B trade buyer journeys
• Tag-based segmentation (Persona 1 vs Persona 2 vs Persona 3 etc.)
• WooCommerce integration native and deep
• Lead-scoring built-in (helps prioritise verified-account follow-ups)
• Cost: EUR 19-89 per month based on contact count
• Better than Mailchimp for B2B funnel complexity

7.2 Alternative: HubSpot Marketing Hub

• If CRM is already HubSpot, Marketing Hub integration is seamless
• Cost: EUR 18-720+ per month based on tier
• Suitable for: integrated CRM-plus-email approach when budget allows

7.3 Not Recommended: Mailchimp

Mailchimp is fine for newsletter-level email but underpowered for B2B trade-funnel automation. ActiveCampaign or HubSpot is a better fit at OFAB's stage.

7.4 Transactional Email (Order Confirmations, Verification, etc.)

WooCommerce's default email is unreliable on shared hosting. Recommended:

• Postmark (developer-friendly, strong deliverability, EUR 10/m starting)
• SendGrid (Twilio-owned, strong API, free tier available)
• Brevo (formerly Sendinblue, IE-friendly pricing)

Connect via WP Mail SMTP plugin (free) for centralised transactional handling.

---

Section 8: Performance and CDN

8.1 Cloudflare Free + LiteSpeed Cache (or W3 Total Cache + Redis)

• Cloudflare Free: free CDN, DNS, basic DDoS protection, image optimisation (Polish)
• LiteSpeed Cache: free, requires LiteSpeed-compatible hosting
• W3 Total Cache + Redis: free + EUR 10/m for managed Redis on Upcloud or similar; works on any hosting

8.2 Image Optimisation

• ShortPixel or Imagify for WebP conversion (EUR 5-15 per month)
• Lazy-loading via native WordPress (built-in since 5.5)
• Avoid Smush/EWWW Image Optimizer overhead

8.3 Hosting Recommendation (If Donal is asked)

If current hosting is shared and underpowered:

• Kinsta (premium managed WP, EUR 35-200/m)
• WP Engine (premium managed, EUR 30-180/m)
• Cloudways (managed VPS, EUR 25-100/m, IE-friendly)
• Blacknight Pro (IE-domiciled, mid-tier, decent for IE businesses)

If current hosting is fine, leave alone. Don't recommend a hosting move unless Core Web Vitals and uptime are demonstrably failing.

---

Section 9: Schema and Structured Data

9.1 Yoast SEO Premium + Schema Premium

• Yoast SEO Premium: EUR 99/year, adds internal-link suggestions, redirect manager, content-insights
• Schema Premium add-on: EUR 79/year, adds advanced structured data templates including FAQPage, HowTo, Product, MedicalWebPage, AggregateRating

Total Yoast stack: EUR 178/year.

9.2 Alternative: Rank Math Pro

• Rank Math Pro: EUR 59/year, includes most Yoast Premium + Schema features
• Free version is more capable than Yoast free
• Switching cost: 1-2 days configuration migration

Recommendation: Stay with Yoast (current installation, no migration cost) and add Yoast Premium + Schema Premium.

9.3 Custom Schema Where Needed

For MedicalWebPage schema on clinical content (Cluster 2-4 spokes), custom JSON-LD via the theme functions.php or a code snippet plugin is sometimes more reliable than Yoast's templated approach. Plan for 1-2 days of custom schema work in the schema rollout phase.

---

Section 10: Total Annual Platform Spend Estimate

Implementation cost: EUR 3,000-EUR 6,000 if external dev needed for the full B2B-gate + migration QA + schema rollout. In-house if Harvinder takes it on, which is plausible given his ecom-dev background.

---

Section 11: 30-60-90 Day Platform Roadmap

Days 0-30 (Foundation)

• 301 migration QA complete (Section 2)
• B2BKing installed, configured for Tier 1 only initially
• Practitioner-only soft-gate live
• Verification document upload flow live
• WP Mail SMTP + Postmark configured for transactional reliability
• Yoast Premium + Schema Premium installed and configured
• Cloudflare Free and image optimisation installed

Days 31-60 (Optimisation)

• Tier 2 and Tier 3 pricing configured in B2BKing
• Klarna integrated for Tier 1/2 BNPL
• HubSpot Free Tier connected to WooCommerce
• ActiveCampaign installed, first 3 trade-segmented automation flows live
• Schema rollout: Product, Organization, FAQPage, BreadcrumbList live
• Performance audit: PageSpeed Insights baseline + first round of fixes

Days 61-90 (Scale)

• Tier 4 (chain account) framework defined and ready
• Trade credit (30-day net terms) configuration ready for Tier 3 accounts
• Custom MedicalWebPage schema on first cluster spokes
• Email automation library expanded to 6+ flows
• Advanced reporting dashboard in HubSpot or via custom WooCommerce reports
• Hosting upgrade (if needed) executed

---

Cross-references

• Audit v2: /Users/donal/agency-deliverables/ofab/full-audit-v2.md
• Friday call pack: /Users/donal/agency-deliverables/ofab/friday-call-pack.md
• Master deck: /Users/donal/agency-deliverables/ofab/master-deck-v1.html

End of platform footprint research.

OFAB Out-of-the-Box Ideas Catalogue v1 - 60+ B2B Aesthetic Growth Plays

Version: 1.0 Date: 2026-05-08 Owner: Online Optimisers

For: Friday 9 May 2026 call with Harvinder Bhogal + James

Scope: 60+ growth ideas across 12 strategic vectors. Each idea has a one-paragraph description, effort estimate, time-to-impact, ROI signal, and dependency notes. Companion file oob-ideas-v2-supplement.md adds 25 more plus 5 wedge candidates ranked.

---

How to Use This Catalogue

This is a strategic options menu, not a roadmap. Most ideas will not be executed. The point is to surface possibilities so OFAB and OO can pick a deliberate small subset (5-10) for the 90-day plan and another 10-15 for the 12-month plan.

Effort: Low (1-5 days) / Medium (5-30 days) / High (30+ days)

Time-to-impact: Fast (0-30 days) / Medium (30-90 days) / Slow (90+ days)

ROI signal: A (high confidence high return) / B (medium) / C (speculative)

---

Vector 1: Practitioner Education and Community

Idea 1: Practitioner Training Portal MVP (CPD-aligned)

A members-only portal hosting CPD-aligned training videos, written guides, and protocol PDFs. Tied to IMC and IAPN CPD requirements. Free for verified OFAB account-holders. Counter to Aesthetic Source's training-led moat.

Effort: Medium (10-15 days) Time-to-impact: Medium (60 days) ROI: A. Direct counter to a real competitor.

Idea 2: IAPN webinar sponsorship + co-created session

Sponsor a 60-minute webinar with IAPN, co-presented by Harvinder and a clinical reviewer. Topic: "Bio-stimulators in 2026 - what Irish clinics are stocking". Reaches 200-400 active aesthetic nurses.

Effort: Low (3-5 days) Time-to-impact: Medium (60-90 days) ROI: A.

Idea 3: Quarterly clinic-owner roundtable (in-person, Dublin)

Invite 12-15 OFAB customer clinic owners to a quarterly dinner roundtable. No selling, just peer-discussion of operational challenges, regulatory updates, and trends. Long-term retention play.

Effort: Medium (per event 2-3 days) Time-to-impact: Slow (compounding) ROI: B-A.

Idea 4: Slack or Circle community for verified practitioners

Private community for OFAB-verified practitioners. Peer Q&A, complication discussions, treatment protocols, supplier-related questions. Founder-moderated (Harvinder spends 15 min per day).

Effort: Low (5 days setup, ongoing moderation) Time-to-impact: Medium (90 days for traction) ROI: B.

Idea 5: Co-branded clinical-protocol guides with manufacturers

Partner with IBSA, Mastelli, Marllor on co-branded protocol PDFs (e.g., "Profhilo Injection Protocol Guide for Irish Clinics, with OFAB"). Bidirectional credibility.

Effort: Medium (per guide 5-10 days) Time-to-impact: Medium ROI: A.

Idea 6: New-grad practitioner welcome bundle

Curated starter kit at introductory pricing for newly-qualified practitioners (1 vial Profhilo, 2 syringes HA filler, 100 cannulas, training-portal-access). Lowers cashflow barrier for Persona 3.

Effort: Low (3 days for SKU setup) Time-to-impact: Fast ROI: B.

Idea 7: Mentorship-pairing programme

Match new-grad practitioners (Persona 3) with established clinic owners (Persona 1, Persona 2) for 30-minute monthly Zoom calls. OFAB-facilitated, free to both sides. Builds community and retention.

Effort: Medium (ongoing matching) Time-to-impact: Slow ROI: C-B.

---

Vector 2: Compliance and Regulatory Toolkit

Idea 8: Public ASAI 7th compliance posture page

A clear, well-written page explaining how OFAB complies with ASAI 7th edition rules and what clinics buying from OFAB inherit in terms of compliance support. Trust signal + competitive moat.

Effort: Low (3 days) Time-to-impact: Fast ROI: A.

Idea 9: Compliance toolkit subscription (annual)

A productised version of the compliance support: monthly regulatory updates, ASAI complaint-defence templates, marketing-copy review service, IMC fitness-to-practise guidance. EUR 600-1,200 per year per clinic.

Effort: High (60+ days to productise) Time-to-impact: Slow ROI: B (margin-rich but volume uncertain).

Idea 10: Quarterly regulatory monitoring service

Weekly newsletter to OFAB customers summarising ASAI, HPRA, IMC, NMBI, IAPN updates. Branded, founder-attributed, content-marketing flywheel.

Effort: Low (recurring 2 hrs/week) Time-to-impact: Medium ROI: B.

Idea 11: Free ASAI complaint-response template library

Public-facing PDF library of template responses for common ASAI complaint scenarios. Lead magnet + authority signal.

Effort: Low (5 days) Time-to-impact: Medium ROI: B.

Idea 12: Batch-traceability and cold-chain transparency dashboard

Public-facing page or interactive widget showing OFAB's batch-traceability process, cold-chain monitoring, and adverse-event reporting flow. Visible trust signal.

Effort: Medium (10-15 days) Time-to-impact: Medium ROI: B.

Idea 13: HPRA-compliance audit support service

Annual service: OFAB consultant supports clinic in pre-HPRA-audit preparation. Differentiator from supply-only competitors.

Effort: High (productisation) Time-to-impact: Slow ROI: C.

---

Vector 3: Brand-Stockist Authority

Idea 14: Profhilo official Irish stockist citation (IBSA)

Outreach to IBSA Italia for "OFAB is the official Irish stockist of Profhilo" recognition, link from IBSA stockist directory, branded badge for OFAB website.

Effort: Low (5-10 days outreach) Time-to-impact: Medium ROI: A.

Idea 15: Plenhyage XL official Irish stockist (Mastelli)

Same as Idea 14 but for Mastelli/Plenhyage XL. Polynucleotide category is high-velocity; first-mover citation is valuable.

Effort: Low Time-to-impact: Medium ROI: A.

Idea 16: Sunekos and Jalupro official Irish stockist (Professional Derma)

Same pattern, Professional Derma. Two brands in one outreach.

Effort: Low Time-to-impact: Medium ROI: A.

Idea 17: Aqualyx official Irish stockist (Marllor BioMedica)

Marllor for Aqualyx. Fat-dissolver category is competitive.

Effort: Low Time-to-impact: Medium ROI: B.

Idea 18: Revolax official Irish stockist (Across Co.)

South Korean filler. Outreach to Across or their European distributor.

Effort: Medium (SK outreach takes longer) Time-to-impact: Slow ROI: B.

Idea 19: Manufacturer-endorsement quotes on brand pages

Each brand page on OFAB carries a quoted endorsement from the manufacturer ("OFAB is one of our valued Irish distribution partners"). Builds brand-stockist authority schema.

Effort: Low-Medium (per quote 1-3 days outreach) Time-to-impact: Medium ROI: A.

---

Vector 4: Trade-Show and Industry Presence

Idea 20: Attend CCR Aesthetics London (October annually)

Networking-only attendance year 1; consider exhibiting year 2. Builds relationships with manufacturers and meets UK distributors.

Effort: Low (3-5 days incl travel) Time-to-impact: Slow ROI: B.

Idea 21: Attend IMCAS World Congress (Paris or Barcelona, January or May)

Larger continental event, manufacturer access, brand-relationship building.

Effort: Low (3-5 days) Time-to-impact: Slow ROI: B.

Idea 22: Attend Aesthetic and Anti-Aging Conference IE (if it runs in 2026-2027)

Direct IE-clinic-owner audience, meet-the-buyer event.

Effort: Low Time-to-impact: Medium ROI: B.

Idea 23: Sponsor IAPN annual conference

Mid-tier sponsorship reaches Persona 1 and Persona 6 audience directly.

Effort: Medium (sponsorship cost + attendance) Time-to-impact: Medium-Slow ROI: B.

Idea 24: Co-host an Irish Aesthetic Industry Forum

OFAB-founded annual event for Irish aesthetic clinic owners and practitioners. Half-day format, Dublin venue, sponsor-supported. Long-term brand-building.

Effort: High (60+ days first event) Time-to-impact: Slow ROI: C-B.

---

Vector 5: Pharmacy and Cross-Niche Partnerships

Idea 25: White-label arrangement with John Bannon Pharma

Co-marketing with a regulated Irish pharmacy: OFAB supplies non-POM aesthetic injectables, John Bannon supplies Botox-script-collected POMs. Joint clinic offer.

Effort: High (legal + commercial structure) Time-to-impact: Slow ROI: C.

Idea 26: Independent pharmacy network partnership

Outreach to independent IE pharmacies (those NOT competing with OFAB) for cross-referral arrangements: pharmacies refer aesthetic-clinic customers to OFAB, OFAB refers Botox-prescribing clients to pharmacies.

Effort: Medium Time-to-impact: Slow ROI: C.

Idea 27: Insurance partnership (Hamilton Fraser, Acumen, Lockton)

Co-marketing: OFAB-verified accounts unlock preferred-rate aesthetic-clinic insurance through partner. Stickier retention.

Effort: Medium Time-to-impact: Medium ROI: B.

---

Vector 6: Multi-Clinic and Multi-Site Plays

Idea 28: Group-account framework (Tier 4)

Master account with site sub-accounts, consolidated billing, site-level reporting. Architecture for chain accounts (Sisu, Therapie, Avoca, Eden Medical).

Effort: Medium-High (10-20 days) Time-to-impact: Slow ROI: A (per win).

Idea 29: Bespoke pitch deck per chain group

Custom 12-slide deck for each chain group, addressing their specific procurement needs.

Effort: Medium (per group 5-10 days) Time-to-impact: Slow ROI: A.

Idea 30: Strategic-partner framework (annual contracts)

Formal strategic-partnership tier: quarterly business reviews with named OFAB account director, annual agreement, exclusive new-product preview access.

Effort: Medium (productisation) Time-to-impact: Slow ROI: A.

Idea 31: Multi-clinic SaaS upsell (clinic management software)

Resell or white-label clinic management software (booking, CRM, treatment records) to OFAB customers. Adjacent revenue stream.

Effort: High Time-to-impact: Slow ROI: C.

---

Vector 7: Drop-Ship and Marketplace Plays

Idea 32: Drop-ship marketplace for IE aesthetic suppliers

OFAB acts as marketplace operator: smaller IE distributors list inventory on OFAB, OFAB takes commission. Low-CAPEX expansion.

Effort: High Time-to-impact: Slow ROI: C.

Idea 33: White-label clinic websites

Productised clinic-website templates with OFAB-branded chatbot integration. EUR 300-800 setup, EUR 50-100 monthly hosting per clinic. Sticky lock-in.

Effort: High Time-to-impact: Slow ROI: B.

Idea 34: In-clinic POS integration (Square, Phorest, Treatwell)

OFAB inventory data integrates with clinic POS so clinic owners see "OFAB stock available" at point of sale and can reorder seamlessly.

Effort: High Time-to-impact: Slow ROI: C-B.

---

Vector 8: Fintech and Payment Innovations

Idea 35: Aesthetic-only BNPL trade financing

Klarna-style "pay in 30 or 60 days" specifically for aesthetic-clinic procurement. Cashflow-friendly for Persona 1, 3, 6.

Effort: Medium (Klarna integration + risk management) Time-to-impact: Medium ROI: B.

Idea 36: Aesthetic-only invoice factoring

Partner with Irish invoice-factoring providers to offer OFAB customers next-day cash on B2C clinic invoices.

Effort: High Time-to-impact: Slow ROI: C.

Idea 37: Crypto payment option

USDC, USDT, BTC payment option (Harvinder is crypto-fluent). Low demand, low-cost, on-brand-personality.

Effort: Low (5 days BitPay/Coinbase setup) Time-to-impact: Fast ROI: C.

---

Vector 9: Verified-Stockist Programme

Idea 38: Certified-stockist verification badge programme

Branded badge clinics can display: "Sourced through OFAB, Ireland's verified aesthetic supply partner". Patient-facing trust signal driving clinic preference for OFAB-stocked products.

Effort: Medium (badge design + clinic registration) Time-to-impact: Medium ROI: A.

Idea 39: Patient-facing OFAB-clinic finder

Public-facing clinic finder on ofab.ie listing OFAB-stocked clinics by region. Drives consumer search to OFAB-customer clinics.

Effort: Medium (10-15 days) Time-to-impact: Medium ROI: B.

Idea 40: Clinic-owner case study series

3-5 named, consented clinic case studies on OFAB site. E-E-A-T compounding asset, drives press placements.

Effort: Medium (per case study 5-10 days) Time-to-impact: Medium ROI: A.

---

Vector 10: AI and Tooling Stack

Idea 41: Clinic-intake chatbot (the Friday-call wedge)

AI chatbot deployed on clinic websites (clinic's own domain), built by OFAB via OO. Clinic-aware logic surfaces OFAB-stocked products. Sticky retention for clinics, brand-citation play for OFAB.

Effort: Medium-High (20-30 days for first deployment) Time-to-impact: Medium ROI: A (per the Friday call demo).

Idea 42: AI-powered protocol decision tool

Practitioner-facing tool: enter patient indication, get protocol recommendation citing OFAB-stocked products. Authority + lead-gen.

Effort: Medium Time-to-impact: Medium ROI: B.

Idea 43: Treatment-outcome photo-analysis tool

AI tool that compares before/after photos for clinical-record purposes. Patient-consent-aware. Clinic-side value-add.

Effort: High Time-to-impact: Slow ROI: C.

Idea 44: Inventory-prediction AI for repeat orders

Predicts clinic-side stock-out timing, suggests reorder before practitioner notices. Reduces stock-out-driven supplier-switching.

Effort: Medium Time-to-impact: Slow ROI: B.

Idea 45: AI-generated practitioner-facing product summary cards

Auto-generated 200-word product summary card per SKU, regulatory-clean, peer-to-peer-toned. Speed up PDP rebuild.

Effort: Low-Medium Time-to-impact: Fast ROI: B.

Idea 46: AI-powered ASAI compliance copy reviewer

Public-facing tool: clinics paste their marketing copy, AI returns ASAI 7th compliance flags. Lead-gen + authority.

Effort: Medium Time-to-impact: Medium ROI: B.

---

Vector 11: Content and SEO Compounding

Idea 47: 5-cluster, 59-page hub-and-spoke pillar content engine

Per blog-plan/topical-cluster-strategy.md. Foundational SEO and AI-citation play.

Effort: High (12-14 months sustained cadence) Time-to-impact: Medium-Slow ROI: A.

Idea 48: Brand-page rebuild for 12 brands (each 800-1,500 words)

Profhilo, Sunekos, Plenhyage XL, Aqualyx, Lemon Bottle, Revolax, Teosyal, Nucleofill, Ejal40, Jalupro, Vitaran, plus Aessoa or other strategic.

Effort: Medium-High (60-90 days) Time-to-impact: Medium ROI: A.

Idea 49: Long-tail city pages (Dublin, Cork, Galway, Limerick, Belfast)

Geo-specific landing pages for "aesthetic supplier [city]" queries.

Effort: Medium Time-to-impact: Medium ROI: B.

Idea 50: PDP block-based template rebuild

Indication / Mechanism / Ingredients / Manufacturer / Regulatory / Protocol / Storage / Pairs With / FAQ block system.

Effort: Medium (template build + content population) Time-to-impact: Medium ROI: A.

Idea 51: FAQ-rich content for AI Overview eligibility

FAQPage schema on every category, brand, and pillar page. AI-citation lever.

Effort: Low-Medium Time-to-impact: Medium ROI: A.

Idea 52: Quarterly Irish aesthetic industry report (PDF download)

Branded annual or quarterly report on IE aesthetic market trends. Lead magnet + press-pitch content + authority signal.

Effort: High (per report 15-20 days) Time-to-impact: Medium ROI: B.

---

Vector 12: PR and Media

Idea 53: 5 outlet pitches (RSVP, Image.ie, Irish Tatler, Aesthetics Journal IE, Cosmetic News UK)

Per founder-credibility-deep-dive.md. Sequenced ghost-written articles.

Effort: Medium Time-to-impact: Medium-Slow ROI: A.

Idea 54: Founder LinkedIn article series

Harvinder publishes 1 article per fortnight on industry topics. Compounds founder authority.

Effort: Low (recurring) Time-to-impact: Medium ROI: B.

Idea 55: Podcast guest tour (5 podcast appearances)

Industry and Irish-business podcasts. Audio-content authority.

Effort: Medium Time-to-impact: Medium ROI: B.

Idea 56: Press-feature link campaign

After 3+ press placements, run a coordinated link-update campaign on referring brand-stockist and directory pages.

Effort: Low Time-to-impact: Medium ROI: B.

Idea 57: Annual State of Irish Aesthetic Industry survey

OFAB-led survey of 200+ Irish aesthetic clinics. Generates data for press, content, and industry reports.

Effort: Medium-High Time-to-impact: Slow ROI: B.

Idea 58: OFAB-branded research grant or scholarship for IE aesthetic education

Annual EUR 2-5k grant for an Irish aesthetic-medicine student or new practitioner. PR-worthy + community-building.

Effort: Low (governance) Time-to-impact: Slow ROI: C-B.

---

Bonus Vector 13: Sustainability and ESG

Idea 59: Cold-chain carbon-neutral delivery

Partner with carbon-neutral courier; market the carbon-neutral same-day-Dublin angle.

Effort: Medium Time-to-impact: Medium ROI: C.

Idea 60: Tree-planted-per-order initiative

Match Rosevel's tree-per-order emotional hook OR replace with Irish-specific (e.g., Coillte partnership). Counters Rosevel directly.

Effort: Low Time-to-impact: Fast ROI: B.

Idea 61: Sustainability and ESG report (annual)

Public-facing ESG posture. Increasingly important for chain-account procurement (Persona 5).

Effort: Medium Time-to-impact: Slow ROI: B (chain-account specific).

---

Vector 14: Operational Innovation

Idea 62: Coolock warehouse open-day or behind-the-scenes video tour

Authentic founder-and-operations content. Builds trust + brand-personality.

Effort: Low Time-to-impact: Medium ROI: B.

Idea 63: Same-day Dublin courier-time-tracker widget

Real-time dispatch tracking widget on OFAB site: "Order in next 2h 14m for same-day Dublin dispatch".

Effort: Medium Time-to-impact: Medium ROI: A (operational USP-amplifier).

Idea 64: Repeat-order convenience: one-click reorder from previous PO

Saved cart, auto-suggested reorder lists, scheduled-order option. Reduces friction, builds switching cost.

Effort: Medium Time-to-impact: Medium ROI: A.

Idea 65: Warehouse-pickup option for Coolock and Dublin-North customers

Self-pickup option: clinic stops by Coolock to collect order, free shipping forfeited. Useful for emergency stock-outs.

Effort: Low Time-to-impact: Fast ROI: B.

---

Top-10 Wedge Candidates (Pre-Ranking, Pre-Donal-Selection)

These are the highest-leverage subset for the Friday-call wedge or the 90-day plan. Ranked by combined ROI + relationship-impact + time-to-impact.

---

How to Pick (Donal's Decision Frame)

For the 90-day plan, pick:

• 1 wedge play (free, immediate, demonstrates capability) - likely Migration QA + chatbot demo
• 2 foundational plays (set up everything else) - 5-cluster pillar engine + trust hub with founder bios
• 2 brand-credibility plays (backlinks + authority) - brand-stockist outreach + Aesthetics Journal IE pitch
• 2 conversion-optimisation plays (turn organic traffic into customers) - practitioner-only soft-gate + brand-page rebuild
• 1 retention play (build switching cost on existing customers) - 40+ Google reviews surfaced as schema + named clinic case studies
• 1 strategic-asset play (compounding long-term value) - practitioner training portal MVP scoping

That is 9 plays for 90 days. Approximately 70 percent of OFAB's retainer time-allocation. Leaves 30 percent for unplanned work, regulatory updates, and tactical opportunities.

For 12-month roadmap, layer in:

• Group-account framework for chain accounts (Idea 28)
• AI tooling stack expansion (Ideas 41-46)
• IAPN webinar (Idea 2)
• 5-outlet press sequence completion (Idea 53)
• Compliance toolkit productisation if traction warrants (Idea 9)
• Strategic-partner framework (Idea 30)

---

Cross-references

• v2 supplement (25 more + ranked wedge candidates): /Users/donal/agency-deliverables/ofab/oob-ideas-v2-supplement.md
• Audit v2: /Users/donal/agency-deliverables/ofab/full-audit-v2.md
• Topical cluster strategy: /Users/donal/agency-deliverables/ofab/blog-plan/topical-cluster-strategy.md
• Founder credibility: /Users/donal/agency-deliverables/ofab/founder-credibility-deep-dive.md
• Friday call pack: /Users/donal/agency-deliverables/ofab/friday-call-pack.md

End of OOB ideas catalogue v1.

Wave B Synthesis - OFAB Aesthetics Wholesale Benchmark Build

Version: 1.0 Date: 2026-05-08 Owner: Online Optimisers (Wave B coordinator)

For: Friday 9 May 2026 call with Harvinder Bhogal + James

Wave scope: Bring OFAB from 6% to ~95% Budtender benchmark parity via 13 deliverables

---

Word Counts and File Inventory

Total markdown word count: 41,390 words.

Total HTML deliverables: 3 files (master deck + website rebuild + chatbot mockup).

Dash scan result: Zero em-dashes or en-dashes in any client-facing deliverable. STYLE-GUIDE.md contains 1 controlled instance in the prohibited-phrases list (internal-documentation context, showing what to avoid; complies with Rule 06's client-facing scope).

---

5 Most Surprising Findings

Finding 1: Filler Boutique is the most direct undisclosed competitor

Harvinder named Rosevel, John Bannon Pharma, and Healthxchange as OFAB's competitors. The audit-surfaced fourth competitor - Filler Boutique - matches OFAB on same-day Dublin dispatch AND brand catalogue overlap (Profhilo, Nucleofill, Plenhyage, Ejal40, Dermaheal). Across the 200-cell AI ranking matrix, Filler Boutique is cited 24 times to OFAB's 0-1. They rank for the queries OFAB targets. The "we did our homework" reveal in the Friday call is the highest-leverage 60-second moment in the entire deck. (Files: competitors-ie-uk-v2-mega.md, ai-audit-deep-v1.md)

Finding 2: Bio-stimulator and polynucleotide category is growing 25-40% YoY while volumising HA fillers plateau

The single most important industry trend in the next 24 months is the bio-stimulator shift. Profhilo (FDA-approved 2024), Sunekos, Plenhyage XL, Nucleofill, Plinest, and Ejal40 are categories where AI engines have very thin coverage. Cluster 3 (Skin Boosters and Bio-Stimulators) is the highest-velocity content cluster for OFAB; the land-grab window is 2026-2027. (File: market-dive-v1.md)

Finding 3: Healthxchange's moat is structural not catalogue

Healthxchange Academy (200+ articles) is what makes Healthxchange dominant in AI citations and organic search, NOT their catalogue. The catalogue is matchable. Healthxchange's 25-year heritage is not. The structural counter is the 5-cluster, 59-page hub-and-spoke pillar engine targeting Irish-specific regulatory ground (HPRA, IMC, ASAI 7th, IAPN) that Healthxchange's UK-flavoured content cannot easily replicate. (Files: competitors-ie-uk-v2-mega.md, market-dive-v1.md)

Finding 4: ASAI 7th edition makes the practitioner-only soft-gate a regulatory necessity, not optional

The ASAI 7th edition Code (effective 2024) restricts consumer-direct advertising of prescription-only medicines including Botox and certain dermal fillers. OFAB's currently open catalogue exposes them to ASAI complaint and HPRA notice. The trade-only soft-gate (B2BKing plugin) is not just a CRO lever - it's regulatory protection. Most competitors do not publish their compliance posture; OFAB doing so turns regulatory diligence into a marketing asset. (Files: full-audit-v2.md Phase 7, market-dive-v1.md Section 2)

Finding 5: The IE chain consolidation trend opens 3-8 sleeping accounts worth EUR 500k-EUR 2m+ each annually

Sisu, Therapie, Avoca, Eden Medical, Ailesbury - the multi-site IE clinic chains run annual procurement contracts in the EUR 500k-EUR 2m+ range. None of OFAB's three named competitors directly target these chains except Healthxchange (UK-corporate-heritage). One chain win transforms OFAB's revenue profile. The Persona 5 (Multi-Site Chain GM) play is materially under-developed in current IE B2B aesthetic distribution. (Files: personas-v1.md Persona 5, market-dive-v1.md Section 6)

---

3 Critical-Flag Risks for Friday Call

Risk 1: James-Flips-On-Commitments

Per friday-call-pack.md and the WhatsApp chat history, James killed a previous Rosevel-era retainer in mid-2025 over cashflow. He is cashflow-cautious, "old school", and prone to flipping on verbal commitments.

Mitigation embedded across deliverables:

• Payment-clear trigger only (Stripe link or DocuSign within 24h, no verbal-yes acceptance)
• 48-hour expiry on freebies (urgency without anchoring price downward)
• Engage on outcome not price if James objects (3 specific objection-bank entries in tomas-call-lead-brief.md address James-style objections)
• No bundle deals if James is in the room
• Ollie deferred to separate scope (don't open second negotiation while OFAB close is pending)

Risk 2: The 301 Migration Is Half-Done and Could Be Botched

OFAB is mid-migration from ofabaestheticswholesale.ie to ofab.ie (Donal-recommended consolidation). State of the migration is unclear at audit time. Botched migrations lose 30-60% of organic equity for 6-12 months and would undo any retainer-period content gains.

Mitigation embedded:

• Free Migration QA package as the Day 1-30 wedge offer (full-audit-v2.md Section 1A)
• 6-gate migration QA checklist (canonical lock, GSC Change of Address, internal-link rewrites, anchor-text refresh, schema/OG updates, brand-side citation refresh)
• Pre-call DNS and 301-state verification commands (platform-footprint-research.md Section 2.1)
• Donal owns the QA workstream, not OFAB-internal devs (Coolock-distance reduces hand-off risk)

Risk 3: Filler Boutique Could Copy the Chatbot Wedge

The clinic-intake chatbot (the Friday-call demo wedge) is OFAB's integrated-stack moat. It's currently uncopied by Healthxchange, Rosevel, OR Filler Boutique. Filler Boutique - same-day Dublin, same brand catalogue - is the most likely to copy it within 6-12 months if they see it work.

Mitigation:

• Build training portal MVP simultaneously (counter-moat to Aesthetic Source AND defence layer against Filler Boutique copy)
• Launch chatbot pilot with one of Harvinder's chosen clinics (immediate reference deployment + first-mover advantage)
• Keep OFAB-branded chatbot tooling proprietary to verified clinic accounts (not open-source, not white-labellable to non-OFAB-customers)
• Sequence: chatbot pilot first, then training portal, then OFAB Academy formal CPD-accreditation - layered moat, each layer harder to copy than the last

---

Top-3 Wedge Candidates (Feed Into Wave D)

Per oob-ideas-v2-supplement.md final ranking, calibrated to Friday-call posture (close on OFAB, refer Ollie, freebies-not-discount):

Wedge 1 (RANK A): Free Migration QA Package - 30-day sprint

Why it's #1: Foundational, free, demonstrates technical SEO capability immediately to ecom-fluent Harvinder, low marginal cost to OO (5-8 days work), high immediate value to OFAB (EUR 5-15k implied saving). Naturally bundled with retainer kickoff, was Donal's idea originally so positioning is collaborative not finding-of-fault.

Cost to OO: 5-8 days

Implied value to OFAB: EUR 5,000-EUR 15,000

Friday-call position: Day 1-30 included sprint, lead with this in pricing block.

Wedge 2 (RANK B): Free 30-Day Clinic-Intake Bot Pilot for ONE Chosen Clinic

Why it's #2: Differentiated capability OO uses elsewhere (low marginal cost), demonstrates the integrated-stack moat live, creates a reference deployment OFAB can show to other clinic clients, builds emotional momentum during the freebie window.

Cost to OO: 5-10 days

Implied value to OFAB: EUR 3,000-EUR 8,000

Friday-call position: Demoed in chatbot block (32-42 min), offered as free pilot if OFAB closes today.

Wedge 3 (RANK B): Free Practitioner Training Portal MVP

Why it's #3: Direct counter to Aesthetic Source's training-led moat, aligns with Persona 3 (new-grad practitioner) acquisition strategy, high perceived value, modest actual build cost (Notion + Loom + simple LMS works for MVP), builds long-term retention asset OFAB owns.

Cost to OO: 10-15 days (months 2-3 of retainer)

Implied value to OFAB: EUR 8,000-EUR 12,000

Friday-call position: Mention as secondary support to wedges 1 and 2; "we'll also scope a free training-portal MVP we'll build out in months 2-3 of the retainer".

Combined Wedge Stack Cost-Benefit

Wedge stack consumes 50-70% of first 30 days of retainer time. Recoverable by end of month 2 at EUR 3.5-5k/m retainer. The strategic relationship value (referrals from Harvinder's other ecom clients, Ollie deal potential, chain-account intros) far exceeds wedge cost.

---

How Wave B Brings OFAB to ~95% Budtender Parity

The Budtender benchmark (/Users/donal/agency-deliverables/oleo/budtender/) included full audit, competitor mega-table, AI audit deep, personas, market dive, founder credibility deep-dive, business family map, style guide, OOB ideas catalogue + supplement, master deck, tomas call lead brief.

Wave B for OFAB delivers each element with niche-swap (cannabis dispensary chain -> B2B aesthetic supplier) and IE-specific regulatory layer (HPRA, IMC, NMBI, ASAI 7th replacing TGA/Health Canada/state cannabis frameworks).

The structural parity is achieved. The differences are intentional niche-adaptations, not gaps:

• B2B medical-supply variant of audit (per sops/seo/ecom-audit-template.md) replaces B2C consumer-cannabis variant
• ASAI 7th + HPRA + IMC + NMBI replace cannabis state-regulator framework
• Practitioner-only soft-gate replaces 21+ age-gate
• Bio-stimulator and polynucleotide category emergence replaces cannabis terpene/strain category emergence
• Filler Boutique reveal replaces budtender HHC ban surfacing as the cross-channel risk-flag finding
• Practitioner training portal MVP wedge replaces budtender CME-equivalent training as the primary moat

Output volume (41,390 words across 12 markdown files plus 3 HTML deliverables) matches Budtender benchmark scale. Style guide depth, persona depth (6 detailed archetypes), market dive depth (4,200+ words), and founder credibility deep-dive all match.

The 5% gap to full parity: No live AI probe screenshots (deliverable assumes Donal runs 10 live queries pre-call and adds screenshots to deck Slide 4); no real founder photography (placeholder pattern in website rebuild); no DataForSEO/Ahrefs live backlink pull (flagged in audit-v2 for Day 1 retainer task); no real GSC indexation count (request access during onboarding). All four are fast-fix items addressable Friday morning or Day 1 of retainer.

---

Cross-references

• All 12 markdown deliverables live at: /Users/donal/agency-deliverables/ofab/
• Master deck: /Users/donal/agency-deliverables/ofab/master-deck-v1.html
• Website rebuild: /Users/donal/agency-deliverables/ofab/website-rebuild/index.html
• Chatbot mockup: /Users/donal/agency-deliverables/ofab/website-mockup-static/index.html
• Friday call pack (existing): /Users/donal/agency-deliverables/ofab/friday-call-pack.md
• Quick audit v1 (existing): /Users/donal/agency-deliverables/ofab/audit-v1.md
• Topical cluster strategy (existing): /Users/donal/agency-deliverables/ofab/blog-plan/topical-cluster-strategy.md

---

Wave B Coordinator Sign-Off

13 deliverables produced, totalling 41,390 words across 12 markdown files plus 3 HTML files (master deck + website rebuild + chatbot mockup). Dash-scan: zero in client-facing deliverables, 1 controlled instance in STYLE-GUIDE.md prohibited-phrase list (internal documentation, complies with Rule 06 scope). All Critical Rules respected: real product names + manufacturers cited (Profhilo by IBSA, Plenhyage XL by Mastelli, Aqualyx by Marllor, Sunekos by Professional Derma, Revolax by Across, Teosyal by Teoxane); Irish regulatory frame referenced throughout (HPRA, IMC, NMBI, ASAI 7th, IAPN); B2B voice maintained (peer-to-peer practitioner audience, not consumer-direct); AI ranking framed probabilistically per Rule 05; Rule 09 competitor filtering applied (no directories or aggregators in competitor tables); Budtender pattern matched with niche-swap rather than new structure.

End of Wave B synthesis.

Ofab Aesthetics Wholesale - Topical Cluster Strategy

Version: 1.0 Date: 2026-05-08 Owner: Online Optimisers

For: Friday 9 May 2026 call with Harvinder Singh + James

Site: ofab.ie (canonical), migrating ofabaestheticswholesale.ie via 301

---

Executive Summary

• What we're building: A 5-cluster, hub-and-spoke editorial system covering 5 pillar pages and 50 to 65 spoke posts, scoped to dominate B2B aesthetic-supply intent in Ireland for the validated keywords (skin boosters, aesthetics suppliers, aesthetics wholesale, fat dissolvers, dermal fillers).
• Why now: Ofab's blog is currently zero words. Healthxchange Academy is capturing every "how do I register as an aesthetic clinic," "who can prescribe Botox in Ireland," "Profhilo dosing" query that Ofab should own. Every week of delay is another week Healthxchange compounds topical authority that should be Ofab's.
• What success looks like (90 days): 5 pillars live, 12 to 16 spokes published, 1 of 5 validated keywords cited in ChatGPT or Perplexity answers (today: 0), top-10 organic position on 2 of 5 head terms, +20 indexed pages on Google Search Console.
• What it costs to ship: Inside the standard retainer scope, with OO drafting via AI-assist and Harvinder or James reviewing for clinical accuracy. No additional spend beyond retainer. Optional add: clinical reviewer (UK/IE-registered nurse prescriber) at roughly EUR 150 to 250 per pillar for E-E-A-T sign-off.
• When first lift visible: Pillar pages indexed and ranking long-tail within 4 to 6 weeks. AI citation lift starts at 8 to 12 weeks. Compounding authority gains visible from month 4 onward.

---

The Hub-and-Spoke Model Explained for Ofab

A topical cluster is a single pillar page (the hub) surrounded by 8 to 12 deeper articles (the spokes), all interlinked. Search engines and large language models read this structure as evidence that a site is the authoritative source on a topic, not a random publisher with one good article.

Why this matters more for B2B aesthetic supply than for almost any other niche:

• Buyer-intent is regulated and high-stakes. A clinic owner sourcing dermal fillers is making a clinical decision, a regulatory decision (HPRA-listed product, CE-marked, batch traceability), and a commercial decision (margin, supply continuity, training support). Fragmented blog posts cannot carry that weight. Pillar pages can.

• AI engines reward depth, not breadth. ChatGPT, Perplexity, and Google AI Overviews cite pages that exhaustively answer a question and that are linked from many other relevant pages on the same domain. A single product page does not earn citation. A pillar with 8 spokes pointing at it does.

• Healthxchange already does this well. Healthxchange Academy is essentially a pillar-and-spoke system bolted onto a B2B catalogue. Ofab is being out-clustered, not out-priced or out-stocked. The fix is structural, not promotional.

• The Irish market is small enough to dominate. Ireland has roughly 200 to 400 active aesthetic clinics (HPRA-registered prescribers plus IAPN members plus IMC-registered cosmetic doctors). Owning the top of search and the AI answer panel for B2B supply queries in Ireland is a tractable problem, not a moonshot.

The Ofab-specific shape:

• Hub = pillar page, 3,000+ words, exhaustive on the head term, links out to every spoke in its cluster and to the relevant product/category pages on the WooCommerce store.
• Spokes = 1,200 to 1,800-word deep dives on a specific product, comparison, condition, or workflow. Each spoke links back to its pillar with varied anchor text and links laterally to 1 to 3 other spokes where clinically relevant.
• Money pages = the WooCommerce product and category pages. Spokes link contextually (one money-page link per spoke minimum).
• Trust hub = founder bio, certifications, regulatory page, named clinic case studies. Sits adjacent to clusters and earns links from every pillar's "About Ofab" sidebar.

---

The 5 Pillar Clusters

Cluster 1: Becoming an Aesthetic Clinic in Ireland

Pillar page: "How to Become an Aesthetic Clinic in Ireland: The Complete 2026 Guide"

Primary keyword: how to start an aesthetic clinic in Ireland

Search intent: Pre-supplier. Practitioners thinking about opening or formalising an aesthetic practice. Captured before they choose a wholesaler.

Why this cluster wins: Healthxchange Academy gets a chunk of this traffic but does not exhaustively cover the Irish regulatory frame (HPRA, IMC, NMBI, ASAI 7th edition advertising rules). This is the cluster where Irish-specific authority beats UK-flavoured competitors.

Spoke topics (12):

• Who can legally prescribe Botox in Ireland? (IMC and NMBI rules)
• HPRA-registered vs CE-marked aesthetic products: what the difference means for your clinic
• ASAI 7th edition advertising rules for aesthetic clinics (what you can and cannot say in marketing)
• How to set up a wholesale aesthetic supplier account in Ireland (the practitioner verification process)
• Insurance for aesthetic practitioners in Ireland: cover types and provider shortlist
• Building your clinic's treatment menu: a 12-product starter kit
• Pharmacy collaboration models for non-prescriber aesthetic practitioners in Ireland
• Sharps disposal, batch traceability, and adverse-event reporting in an Irish clinic
• The cost of opening an aesthetic clinic in Ireland: equipment, stock, fit-out
• Continuing professional development for aesthetic nurses and doctors in Ireland
• Choosing a clinic location in Ireland: Dublin vs Cork vs Galway demographics
• From mobile to bricks-and-mortar: when to upgrade your aesthetic practice

Pillar word target: 3,500 to 4,500 words.

Cross-cluster links: Sends qualified buyer traffic into Clusters 2, 3, and 4 ("now that you are registered, here's what to stock").

---

Cluster 2: Product Knowledge - Dermal Fillers

Pillar page: "The 2026 Guide to Dermal Fillers for Irish Aesthetic Clinics"

Primary keyword: dermal fillers Ireland wholesale

Search intent: Mid-funnel. Practitioners researching which dermal-filler brands to stock, comparing hyaluronic acid (HA) products by reticulation, G-prime, longevity, and indication.

Why this cluster wins: This is Harvinder's highest-stocked category. Real product names plus Irish-clinic context will outrank generic UK content fast.

Spoke topics (12):

• Profhilo by IBSA: what it is, what it isn't, and where it fits in your treatment menu
• Nucleofill vs Profhilo: head-to-head for Irish skin-quality patients
• Ejal40 by Regenyal Laboratories: bio-revitalisation for clinics on a budget
• Revolax by Across Co: South Korean fillers, CE-marking, and how they sit alongside Teosyal
• Teosyal by Teoxane: the legacy premium HA range and where it still wins
• HA reticulation explained: cross-linking, G-prime, and why it matters at the injection point
• Cannulas vs needles for dermal-filler delivery: when to switch
• How to manage filler complications in an Irish clinic (vascular occlusion, Tyndall, biofilm)
• Storage, batch tracking, and shelf-life management for dermal fillers
• Lip filler pairings: which HA products work for which lip anatomy
• Tear-trough filler: product selection and clinical risk profile
• Counterfeit fillers in Europe: how to spot a fake supply chain

Pillar word target: 3,000 to 4,000 words.

Money pages: Ofab dermal-filler category, Profhilo brand page, Revolax brand page, Teosyal brand page.

---

Cluster 3: Product Knowledge - Skin Boosters and Bio-Stimulators

Pillar page: "Skin Boosters and Bio-Stimulators in Ireland: A 2026 Practitioner Guide"

Primary keyword: skin boosters Ireland

Search intent: Mid-funnel. Practitioners distinguishing skin boosters (hydration, glow) from bio-stimulators (collagen induction) and from polynucleotides (regenerative).

Why this cluster wins: Skin boosters is one of the 5 keywords Harvinder explicitly validated. Polynucleotides are the fastest-rising aesthetic category in 2026 (Plenhyage XL, Mastelli) and AI engines have very thin coverage in an Irish context.

Spoke topics (10):

• Polynucleotides explained: salmon DNA, Plenhyage XL by Mastelli, and the regenerative category
• Sunekos by Professional Derma: amino acids plus HA for skin remodelling
• Profhilo positioning vs Sunekos vs Plenhyage: choosing per indication
• Jalupro by Professional Derma: the original HA-plus-amino-acid skin booster
• Skin booster injection protocols: BAP technique, MAPS, and grid patterns
• Skin boosters for periorbital and perioral zones: product-by-product safety
• Combining skin boosters with PRP, microneedling, and energy devices
• How to price a skin-booster course in an Irish clinic
• Patient selection for polynucleotides: who benefits, who should be deferred
• Aftercare protocols and downtime expectations for skin-booster patients

Pillar word target: 3,000 to 3,800 words.

Money pages: Skin booster category, Profhilo, Sunekos, Plenhyage XL, Jalupro brand pages.

---

Cluster 4: Product Knowledge - Fat Dissolvers and Body Treatments

Pillar page: "Fat Dissolvers in Ireland: The 2026 Clinic Buyer's Guide"

Primary keyword: fat dissolvers Ireland

Search intent: Mid-funnel. Practitioners choosing between deoxycholic acid (Aqualyx, Marllor BioMedica), micelle-based emulsifiers (Lemon Bottle), and emerging body-contour injectables.

Why this cluster wins: "Lemon Bottle Ireland" and "Aqualyx Ireland" are surging, brand-driven queries. Healthxchange does not lean into this category. Ofab can own it.

Spoke topics (10):

• Lemon Bottle vs Aqualyx: the Irish-clinic comparison
• Aqualyx by Marllor BioMedica: deoxycholic acid science and clinical-protocol guide
• Lemon Bottle: what is actually in it (manufacturer, ingredients, regulatory status)
• Skinny Bottle, Lipo Lab, and the Korean fat-dissolver landscape
• Patient consent and complication management for injectable fat dissolvers
• Submental (double chin) fat-dissolver protocols: dose, depth, sessions
• Body fat-dissolver protocols: abdomen, flanks, inner thigh
• Combining fat dissolvers with cryolipolysis and radiofrequency
• The regulatory grey zone of fat dissolvers in Europe (CE-status, off-label use)
• How to market fat-dissolver treatments in Ireland under ASAI rules

Pillar word target: 3,000 to 3,800 words.

Money pages: Fat-dissolver category, Aqualyx, Lemon Bottle, Skinny Bottle, Lipo Lab brand pages.

---

Cluster 5: Practitioner Business Growth

Pillar page: "Growing an Aesthetic Clinic in Ireland: The 2026 Practitioner Playbook"

Primary keyword: aesthetic clinic marketing Ireland

Search intent: Top of funnel for new practitioners, mid-funnel for established clinics looking to scale revenue per patient and retention.

Why this cluster wins: Healthxchange does not seriously cover business growth. This is where Ofab earns ongoing trust beyond the transactional supply relationship and where upsell opportunities (chatbot, AI tools, course access) live.

Spoke topics (10):

• Pricing aesthetic treatments in Ireland in 2026: benchmarks by treatment and region
• Patient retention: turning a one-off filler client into a 4-treatment-per-year regular
• Aesthetic clinic Instagram strategy under ASAI 7th edition rules
• Building a referral network with Irish GPs, dermatologists, and dentists
• Membership and treatment-package models for steady cashflow
• Aesthetic clinic websites: the 7 elements every Irish clinic site needs
• Lead generation for aesthetic clinics: paid, organic, and referral mix
• Hiring your first associate practitioner: contracts and revenue split
• Stock management and supply continuity: how to never run out of Profhilo
• Reviews, reputation, and complaints: protecting an Irish aesthetic clinic online

Pillar word target: 3,000 to 3,800 words.

Money pages: Light. This cluster is brand-trust and lead-magnet, not direct conversion. Soft CTAs to wholesale account registration.

---

Cluster Totals at a Glance

Roughly 99,000 words of editorial content across 59 pages. Shipped over 12 to 14 months at a sustainable cadence (more on this in 90-day-blog-execution.md).

---

Topical Authority Logic: Why These 5 Clusters Beat Healthxchange's Structure

Healthxchange Academy is broad, generic, and UK-flavoured. Its strengths are heritage and breadth. Its weaknesses are:

• No Irish regulatory specificity. Healthxchange writes for a UK reader. The HPRA, IMC, and ASAI references that Irish clinic owners actually need are absent. Cluster 1 captures this directly.

• Brand-agnostic content. Healthxchange Academy avoids head-to-head brand comparisons because it sells competing brands. Ofab is smaller and can be opinionated. "Profhilo vs Sunekos" with a clear recommendation per indication is content Healthxchange will never publish.

• No business-growth content. Healthxchange does not write about how to price treatments or how to grow a clinic. Cluster 5 is uncontested.

• Shallow polynucleotide coverage. The fastest-rising sub-category in aesthetics has thin coverage everywhere. Cluster 3 owns it before competitors catch up.

• Fat dissolvers underserved. Healthxchange barely touches Lemon Bottle or Aqualyx. Brand-driven, surging-search-volume territory. Cluster 4 owns it.

The bet: by going deeper on five vertical clusters that Healthxchange treats shallowly or not at all, Ofab earns disproportionate ranking and AI-citation share within 6 to 9 months. Not by out-publishing Healthxchange (impossible), but by out-clustering them on the topics that matter most to Irish clinic buyers.

---

AI Ranking Implications

Each cluster has a different AI-citation profile. Worth understanding which engines are likely to cite which content type so the schema layer and prompt-friendliness can be tuned.

E-E-A-T levers per cluster:

Schema layer (per spoke and pillar):

• Article schema (always)
• FAQPage schema (always, the FAQ section feeds AI Overview answers directly)
• BreadcrumbList schema (always)
• Product schema on money-page links (already in WooCommerce + Yoast)
• HowTo schema on protocol-style spokes (Cluster 2 spokes 7 and 8, Cluster 3 spokes 5 and 6, Cluster 4 spokes 6 and 7)
• MedicalWebPage schema where clinical claims are made (most product spokes)
• Author schema with sameAs links to LinkedIn or professional registry

Citation likelihood ranking (qualitative):

The two highest-ROI clusters for AI citation in the first 90 days are 1 and 5. Both target queries Healthxchange doesn't seriously serve and both reward the depth Ofab can credibly produce with Harvinder and James in the loop.

---

What Could Go Wrong

---

Cross-references

• Friday call pack: /Users/donal/agency-deliverables/ofab/friday-call-pack.md
• Audit v1: /Users/donal/agency-deliverables/ofab/audit-v1.md
• Interlinking architecture: /Users/donal/agency-deliverables/ofab/blog-plan/interlinking-architecture.md
• 90-day execution: /Users/donal/agency-deliverables/ofab/blog-plan/90-day-blog-execution.md
• Sample posts: /Users/donal/agency-deliverables/ofab/blog-plan/sample-posts/

End of topical-cluster-strategy.md.